OO_898的个人主页 - 老虎社区

OO_898

OO_898

暂无个人介绍

IP属地：未知

313关注

23粉丝

0主题

0勋章

2021-12-16

Like

Blackberry News: The BMW Deal Bouncing BB Stocky

2021-12-11

Like

U.S. to sell 18 mln barrels of oil from reserves on Dec 17

2021-12-11

Like

抱歉，原内容已删除

2021-12-11

Like

Ford expects to triple electric Mustang output by 2023

2021-12-11

Like

抱歉，原内容已删除

2021-12-11

Like

抱歉，原内容已删除

2021-12-11

Like

抱歉，原内容已删除

2021-12-11

Like

3M hit with $22.5 million verdict in latest U.S. military earplug trial

2021-12-10

Like

外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了

2021-12-10

Looking forward [Grin]

Will Apple Stock’s Rally Fizzle Out? Don’t Bet on It.

2021-12-10

Like

外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了

2021-12-09

[Cry]

Grab stock dropped more than 6% in morning trading

2021-12-05

Like

China’s Asymchem Said to Guide Listing Price at HK$388

2021-12-05

Like

Tesla's Musk over halfway through his pledge with nearly $11 bln stake sale

2021-12-05

Like

Wall St ends lower on Omicron worries, Fed taper angst

2021-12-05

Like

DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'

2021-12-05

Like

Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock

2021-12-05

Like

抱歉，原内容已删除

2021-12-05

Like

抱歉，原内容已删除

2021-12-05

Like

US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3582969710070724","uuid":"3582969710070724","gmtCreate":1619875907024,"gmtModify":1622699637564,"name":"OO_898","pinyin":"oo898oo898","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":313,"tweetSize":754,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.06","exceedPercentage":"80.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"02aa7f16703b4ce4ace6f1a7665789cc-1","templateUuid":"02aa7f16703b4ce4ace6f1a7665789cc","name":"知识体验官","description":"观看学堂课程满5节","bigImgUrl":"https://static.tigerbbs.com/fb5ae275631fb96a92d475cdc85d2302","smallImgUrl":"https://static.tigerbbs.com/c2660a1935bd2105e97c9915619936c3","grayImgUrl":null,"redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":2006},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":6,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":690982997,"gmtCreate":1639621819858,"gmtModify":1639621820107,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690982997","repostId":"1199047170","repostType":2,"repost":{"id":"1199047170","kind":"news","pubTimestamp":1639621171,"share":"https://www.laohu8.com/m/news/1199047170?lang=&edition=full","pubTime":"2021-12-16 10:19","market":"us","language":"en","title":"Blackberry News: The BMW Deal Bouncing BB Stocky","url":"https://stock-news.laohu8.com/highlight/detail?id=1199047170","media":"InvestorPlace","summary":"Blackberry(NYSE:BB) stock is on the move Wednesday after announcing a multi-year agreement with Baye","content":"<p><b>Blackberry</b>(NYSE:<b><u>BB</u></b>) stock is on the move Wednesday after announcing a multi-year agreement with&nbsp;<b>Bayerische Motoren Werke</b>(OTCMKTS:<b><u>BMWYY</u></b>).</p>\n<p>According to&nbsp;a press release, Blackberry has signed a deal with BMW that will have the two working together to develop technology for the latter’s next generation of vehicles. That includes the licensing of BB’s QNX tech and sending a support group of engineers to help with vehicle automation plans.</p>\n<p>Blackberry notes that this will have its engineers working on new SAE Level 2/2+ self-driving functions. The goal would be for this to end up in multiple vehicles across different makes and models.</p>\n<p>The initial news of the BMW deal sent BB stock higher when shares started trading this morning. However, the stock didn’t retain those gains and quickly started to sink back down to its closing price on Tuesday.</p>\n<p>It’s worth noting that BB is a meme stock, which means it’s often subject to volatility. That’s exacerbated by the fact the shares trade below $10 each. This makes it easier for traders to get into the stock when news like this comes around. That results in it running higher before eventually falling.</p>\n<p>Backing that up is decent trading of BB stock today. The company has seen roughly 9 million shares change hands as of this writing. That’s close to its daily average trading volume of about 9.3 million shares.</p>\n<p>BB stock is up 3.84% as of Wednesday afternoon but is still up 34.69% since the start of the year.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Blackberry News: The BMW Deal Bouncing BB Stocky</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBlackberry News: The BMW Deal Bouncing BB Stocky\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 10:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/blackberry-news-the-bmw-deal-bouncing-bb-stock-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Blackberry(NYSE:BB) stock is on the move Wednesday after announcing a multi-year agreement with Bayerische Motoren Werke(OTCMKTS:BMWYY).\nAccording to a press release, Blackberry has signed a deal with...</p>\n\n<a href=\"https://investorplace.com/2021/12/blackberry-news-the-bmw-deal-bouncing-bb-stock-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BB":"黑莓","BMWYY":"宝马汽车"},"source_url":"https://investorplace.com/2021/12/blackberry-news-the-bmw-deal-bouncing-bb-stock-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199047170","content_text":"Blackberry(NYSE:BB) stock is on the move Wednesday after announcing a multi-year agreement with Bayerische Motoren Werke(OTCMKTS:BMWYY).\nAccording to a press release, Blackberry has signed a deal with BMW that will have the two working together to develop technology for the latter’s next generation of vehicles. That includes the licensing of BB’s QNX tech and sending a support group of engineers to help with vehicle automation plans.\nBlackberry notes that this will have its engineers working on new SAE Level 2/2+ self-driving functions. The goal would be for this to end up in multiple vehicles across different makes and models.\nThe initial news of the BMW deal sent BB stock higher when shares started trading this morning. However, the stock didn’t retain those gains and quickly started to sink back down to its closing price on Tuesday.\nIt’s worth noting that BB is a meme stock, which means it’s often subject to volatility. That’s exacerbated by the fact the shares trade below $10 each. This makes it easier for traders to get into the stock when news like this comes around. That results in it running higher before eventually falling.\nBacking that up is decent trading of BB stock today. The company has seen roughly 9 million shares change hands as of this writing. That’s close to its daily average trading volume of about 9.3 million shares.\nBB stock is up 3.84% as of Wednesday afternoon but is still up 34.69% since the start of the year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605440663,"gmtCreate":1639230747553,"gmtModify":1639230747838,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605440663","repostId":"2190673907","repostType":4,"repost":{"id":"2190673907","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639173100,"share":"https://www.laohu8.com/m/news/2190673907?lang=&edition=full","pubTime":"2021-12-11 05:51","market":"us","language":"en","title":"U.S. to sell 18 mln barrels of oil from reserves on Dec 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2190673907","media":"Reuters","summary":"Dec 10 (Reuters) - The U.S. Department of Energy said on Friday it will sell 18 million barrels of c","content":"<p>Dec 10 (Reuters) - The U.S. Department of Energy said on Friday it will sell 18 million barrels of crude oil from its strategic petroleum reserve <a href=\"https://laohu8.com/S/SPR\">$(SPR)$</a> on Dec. 17, as part of a previously announced plan to try to reduce oil prices.</p>\n<p>The Biden Administration announced last month it would release about 50 million barrels from its reserves in conjunction with other countries to combat the rising cost of fuel.</p>\n<p>The White House has been trying to deal with Americans' worries about high fuel costs, even though the president has few tools to deal with the price of crude, a global market influenced by numerous factors.</p>\n<p>“The President rightly believes Americans deserve relief now and has authorized the use of the SPR to respond to market imbalances and reduce costs for consumers,\" said  Energy Secretary Jennifer Granholm.</p>\n<p>Oil prices rose to seven-year highs at more than $86 a barrel due to surging fuel demand worldwide, but have dropped by nearly 13% since late October, in part due to the U.S. announcement and the emergence of the Omicron variant of coronavirus that has dented travel around the world.</p>\n<p>The Brent benchmark ended at $75.15 a barrel on Friday.</p>\n<p>The 18 million barrels to be sold had already been approved by Congress in 2018. The remaining barrels will be issued in coming months through exchanges. The first exchange of 4.8 million barrels will be with Exxon Mobil Corp , the largest U.S. oil company.</p>\n<p>U.S. retail gas prices are currently averaging $3.33 a gallon, the lowest since mid-October, according to the American Automobile Association. Prices peaked at $3.42 a gallon early in November.</p>\n<p>The United States holds roughly 600 million barrels of crude oil in giant caverns in Texas and Louisiana. Its current inventory is at its lowest since 2003.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. to sell 18 mln barrels of oil from reserves on Dec 17</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. to sell 18 mln barrels of oil from reserves on Dec 17\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 05:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - The U.S. Department of Energy said on Friday it will sell 18 million barrels of crude oil from its strategic petroleum reserve <a href=\"https://laohu8.com/S/SPR\">$(SPR)$</a> on Dec. 17, as part of a previously announced plan to try to reduce oil prices.</p>\n<p>The Biden Administration announced last month it would release about 50 million barrels from its reserves in conjunction with other countries to combat the rising cost of fuel.</p>\n<p>The White House has been trying to deal with Americans' worries about high fuel costs, even though the president has few tools to deal with the price of crude, a global market influenced by numerous factors.</p>\n<p>“The President rightly believes Americans deserve relief now and has authorized the use of the SPR to respond to market imbalances and reduce costs for consumers,\" said  Energy Secretary Jennifer Granholm.</p>\n<p>Oil prices rose to seven-year highs at more than $86 a barrel due to surging fuel demand worldwide, but have dropped by nearly 13% since late October, in part due to the U.S. announcement and the emergence of the Omicron variant of coronavirus that has dented travel around the world.</p>\n<p>The Brent benchmark ended at $75.15 a barrel on Friday.</p>\n<p>The 18 million barrels to be sold had already been approved by Congress in 2018. The remaining barrels will be issued in coming months through exchanges. The first exchange of 4.8 million barrels will be with Exxon Mobil Corp , the largest U.S. oil company.</p>\n<p>U.S. retail gas prices are currently averaging $3.33 a gallon, the lowest since mid-October, according to the American Automobile Association. Prices peaked at $3.42 a gallon early in November.</p>\n<p>The United States holds roughly 600 million barrels of crude oil in giant caverns in Texas and Louisiana. Its current inventory is at its lowest since 2003.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"XOM":"埃克森美孚","BK4187":"航天航空与国防","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","SPR":"Spirit AeroSystems Holdings Inc","BK4516":"特朗普概念","BK4201":"综合性石油与天然气企业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190673907","content_text":"Dec 10 (Reuters) - The U.S. Department of Energy said on Friday it will sell 18 million barrels of crude oil from its strategic petroleum reserve $(SPR)$ on Dec. 17, as part of a previously announced plan to try to reduce oil prices.\nThe Biden Administration announced last month it would release about 50 million barrels from its reserves in conjunction with other countries to combat the rising cost of fuel.\nThe White House has been trying to deal with Americans' worries about high fuel costs, even though the president has few tools to deal with the price of crude, a global market influenced by numerous factors.\n“The President rightly believes Americans deserve relief now and has authorized the use of the SPR to respond to market imbalances and reduce costs for consumers,\" said  Energy Secretary Jennifer Granholm.\nOil prices rose to seven-year highs at more than $86 a barrel due to surging fuel demand worldwide, but have dropped by nearly 13% since late October, in part due to the U.S. announcement and the emergence of the Omicron variant of coronavirus that has dented travel around the world.\nThe Brent benchmark ended at $75.15 a barrel on Friday.\nThe 18 million barrels to be sold had already been approved by Congress in 2018. The remaining barrels will be issued in coming months through exchanges. The first exchange of 4.8 million barrels will be with Exxon Mobil Corp , the largest U.S. oil company.\nU.S. retail gas prices are currently averaging $3.33 a gallon, the lowest since mid-October, according to the American Automobile Association. Prices peaked at $3.42 a gallon early in November.\nThe United States holds roughly 600 million barrels of crude oil in giant caverns in Texas and Louisiana. Its current inventory is at its lowest since 2003.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1014,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605440106,"gmtCreate":1639230692806,"gmtModify":1639230714081,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605440106","repostId":"2190002673","repostType":4,"isVote":1,"tweetType":1,"viewCount":1387,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605457590,"gmtCreate":1639230644565,"gmtModify":1639230644840,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605457590","repostId":"2190484675","repostType":4,"repost":{"id":"2190484675","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639186463,"share":"https://www.laohu8.com/m/news/2190484675?lang=&edition=full","pubTime":"2021-12-11 09:34","market":"us","language":"en","title":"Ford expects to triple electric Mustang output by 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2190484675","media":"Reuters","summary":"Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV","content":"<p>Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.</p>\n<p>\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added</p>\n<p>In a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .</p>\n<p>Last week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.</p>\n<p>Lisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.</p>\n<p>Automotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about <a href=\"https://laohu8.com/S/AONE.U\">one</a> and a half years to increase manufacturing of its Mustang Mach-E SUVs.</p>\n<p>Ford told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.</p>\n<p>Ford did not immediately respond to a request for comment on the Automotive News report.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford expects to triple electric Mustang output by 2023</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord expects to triple electric Mustang output by 2023\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.</p>\n<p>\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added</p>\n<p>In a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .</p>\n<p>Last week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.</p>\n<p>Lisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.</p>\n<p>Automotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about <a href=\"https://laohu8.com/S/AONE.U\">one</a> and a half years to increase manufacturing of its Mustang Mach-E SUVs.</p>\n<p>Ford told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.</p>\n<p>Ford did not immediately respond to a request for comment on the Automotive News report.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车","BK4099":"汽车制造商","BK4555":"新能源车","GM":"通用汽车","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190484675","content_text":"Dec 10 (Reuters) - Ford Motor Co expects to triple the output of its all-electric Mustang Mach-E SUV to over 200,000 units per year by 2023 for North America and Europe, its Chief Executive Officer Jim Farley said in a tweet on Friday.\n\"It's hard to produce Mustang Mach-Es fast enough to meet the incredible demand, but we are sure going to try.\" Farley added\nIn a hot electrical vehicle market, Ford is pitting itself against the likes of century-old rival General Motors Co and European carmaker Stellantis , while chasing Volkswagen and global EV leader Tesla Inc .\nLast week, a top Ford executive said that the company was aiming for annual EV production capacity of nearly 600,000 within the next two years, which would also include its Lightning pickup and E-Transit van.\nLisa Drake, the chief operating officer of Ford North America, said that the company's optimism stemmed from increasing demand for its F-150 Lightning pickup, with retail reservations approaching 200,000.\nAutomotive News reported earlier on Friday that Ford was postponing the production of electric versions of the Explorer and Lincoln Aviator crossovers by about one and a half years to increase manufacturing of its Mustang Mach-E SUVs.\nFord told its suppliers that production of these new EVs is now scheduled to start in December 2024, according to the report.\nFord did not immediately respond to a request for comment on the Automotive News report.","news_type":1},"isVote":1,"tweetType":1,"viewCount":931,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605457314,"gmtCreate":1639230483343,"gmtModify":1639230483618,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605457314","repostId":"2190205546","repostType":4,"isVote":1,"tweetType":1,"viewCount":1325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605457087,"gmtCreate":1639230435877,"gmtModify":1639230436120,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605457087","repostId":"2190620320","repostType":4,"isVote":1,"tweetType":1,"viewCount":2163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605454626,"gmtCreate":1639230310665,"gmtModify":1639230310945,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605454626","repostId":"2190275356","repostType":4,"isVote":1,"tweetType":1,"viewCount":1693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605455750,"gmtCreate":1639230069371,"gmtModify":1639230069609,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/605455750","repostId":"2190675480","repostType":4,"repost":{"id":"2190675480","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639187514,"share":"https://www.laohu8.com/m/news/2190675480?lang=&edition=full","pubTime":"2021-12-11 09:51","market":"us","language":"en","title":"3M hit with $22.5 million verdict in latest U.S. military earplug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2190675480","media":"Reuters","summary":"Dec 10  - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by $3M$ Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.Finley, who used th","content":"<p>Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by <a href=\"https://laohu8.com/S/MMM\">3M</a> Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.</p>\n<p>Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.</p>\n<p>Finley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.</p>\n<p>The trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.</p>\n<p>\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.</p>\n<p>3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.</p>\n<p>Aearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.</p>\n<p>For the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.</p>\n<p>(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)</p>\n<p>((Nate.Raymond@thomsonreuters.com and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3M hit with $22.5 million verdict in latest U.S. military earplug trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3M hit with $22.5 million verdict in latest U.S. military earplug trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by <a href=\"https://laohu8.com/S/MMM\">3M</a> Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.</p>\n<p>Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.</p>\n<p>Finley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.</p>\n<p>The trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.</p>\n<p>\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.</p>\n<p>3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.</p>\n<p>Aearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.</p>\n<p>For the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.</p>\n<p>(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)</p>\n<p>((Nate.Raymond@thomsonreuters.com and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","MMM":"3M","BK4512":"苹果概念","BK4206":"工业集团企业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190675480","content_text":"Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by 3M Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.\nJurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.\nFinley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.\nThe trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.\n\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.\n3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.\nAearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.\nFor the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.\n(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)\n((Nate.Raymond@thomsonreuters.com and Twitter @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605146044,"gmtCreate":1639135478416,"gmtModify":1639135478710,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605146044","repostId":"2190343645","repostType":2,"repost":{"id":"2190343645","kind":"news","pubTimestamp":1639085987,"share":"https://www.laohu8.com/m/news/2190343645?lang=&edition=full","pubTime":"2021-12-10 05:39","market":"hk","language":"zh","title":"外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了","url":"https://stock-news.laohu8.com/highlight/detail?id=2190343645","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险</b>\n</blockquote>\n<blockquote>\n <b>2、美国商务部长称若不能解决芯片危机会造成毁灭性影响</b>\n</blockquote>\n<blockquote>\n <b>3、美国家庭净资产创疫后复苏以来最低增幅</b>\n</blockquote>\n<blockquote>\n <b>4、美国CPI数据恐进一步攀升 <a href=\"https://laohu8.com/S/BLK\">贝莱德</a>：现在是时候对冲通胀了</b>\n</blockquote>\n<blockquote>\n <b>5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响</b>\n</blockquote>\n<blockquote>\n <b>6、尽管面临疫情挑战 标普仍预计明年石油需求将增长</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/171ee93eeb2ef6ad06cf1393d17fe165\" tg-width=\"720\" tg-height=\"461\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险</b></p>\n<p>国际货币基金组织（IMF）首席经济学家周四表示，各国央行没有空间维持宽松的货币政策和低利率，并警告说，新冠疫情的代价可能远高于预期。</p>\n<p>IMF首席经济学家Gita Gopinath表示，除了目前预计的12.5万亿美元损失之外，像奥密克戎（Omicron）这样更易传播的新冠变体可能会使全球经济再损失5.3万亿美元。</p>\n<p>“我们现在处于这样一个阶段，全球各国根本没有空间保持非常宽松的货币政策，将利率维持在极低的水平。我们看到全球各地的通胀压力都在积聚，”她说。</p>\n<p>Gopinath补充说：“因此，想想这样一种情况，疫情可能会持续更长时间，供应中断时间会更长，从而带来通胀压力，然后我们面临着真正风险，即滞胀担忧。”</p>\n<p><img src=\"https://static.tigerbbs.com/5212ae28f04e24df1b80bd53b47e900c\" tg-width=\"720\" tg-height=\"541\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国商务部长称若不能解决芯片危机会造成毁灭性影响</b></p>\n<p>美国商务部长雷蒙多表示，如果国会不马上通过拜登政府旨在缓解芯片短缺问题的法案，对美国经济将产生“毁灭性”影响。</p>\n<p>“延后通过的后果再怎么说都不夸张，”雷蒙多周四接受采访时称。“如果不能在圣诞节前完成，就必须在1月完成，因为长期回避这个问题的后果对我们的经济和国家安全来说确实是毁灭性的，”她说道。</p>\n<p>雷蒙多一直在敦促国会通过《芯片法案》以提供520亿美元帮助计算机芯片制造商，缓解供应短缺局面。</p>\n<p>德克萨斯州共和党参议员John Cornyn周三表示，《芯片法案》可能要到2月才能通过。</p>\n<p><img src=\"https://static.tigerbbs.com/a6b793e107dcfc6eafc907b0b32a952c\" tg-width=\"720\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国家庭净资产创疫后复苏以来最低增幅</b></p>\n<p>美国家庭净资产增速在第三季度降温，股市的暂时回撤抵消了房价上涨的财富效应。</p>\n<p>美联储周四发布的数据显示，在第二季度增加6.14万亿美元之后，家庭净资产在第三季度增加近2.4万亿美元，增幅为1.7%。虽然季度增量是疫情复苏中最小的一次。</p>\n<p>第三季度增长包括家庭房地产增值1.4万亿美元，但股票价值减少近3200亿美元。</p>\n<p>不过，并非所有人都从大流行期间的股价飙升和房地产热潮中受益。调查数据表明，仅有略多于一半的美国人持有股票。而对于租房居住的大约三分之一家庭来说，租金正在迅速上升。</p>\n<p>较高的储蓄水平仍然是家庭支出的一个重要来源，不过随着联邦政府刺激措施的减弱，储蓄有所下降。第三季度私人储蓄净额折年率增长2.84万亿美元，为2020年初以来最慢增速。</p>\n<p><img src=\"https://static.tigerbbs.com/c01e6086ac39e2b3a4bd7ceb2827ad79\" tg-width=\"720\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国CPI数据恐进一步攀升 <a href=\"https://laohu8.com/S/BLK\">贝莱德</a>：现在是时候对冲通胀了</b></p>\n<p>贝莱德的Gargi Chaudhuri预计周五的通胀数据将超过华尔街的预期，并建议投资者对冲更高的通胀。</p>\n<p>“我们可能会得到比市场定价略强一些的东西，”这位贝莱德<a href=\"https://laohu8.com/S/EEME\">iShares</a>安硕美洲投资策略主管周四接受采访时表示。“我预计市场中的部分商品门类以及服务领域会更强劲，例如住房通胀。”</p>\n<p>通胀处于数十年来的最高水平。根据经济学家预测，周五的数据显示11月份通胀率达到6.8%，将是里根时代以来的最高水平，也是许多美国人有生以来遇到的最高通胀。</p>\n<p>Chaudhuri表示，她预计2022年晚些时候通胀将放缓，而商品和服务价格将保持在疫情前水平之上。为了保护自己，投资者应该关注那些能够抵御通胀侵蚀回报的资产，例如“能够转嫁价格上涨的公司的股票”。</p>\n<p><img src=\"https://static.tigerbbs.com/fcc456868080840479884603ed672cd3\" tg-width=\"720\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国上周首次申请失业救济人数降至52年最低 受季节性因素影响</b></p>\n<p>美国上周首次申请失业救济人数降至1969年以来最低水平，凸显出对数据进行季节性调整的难度。</p>\n<p>美国劳工部周四发布的数据显示，截至12月4日的一周，首次申领失业救济人数比前一周减少4.3万，至18.4万人。经济学家中值预期为22万人。</p>\n<p>此前两周该数据已经出现大幅下降，许多经济学家将其归因于假期前后季节性波动因素导致数据调整难度较大。未经调整的首次申领失业救济人数增加约64000人。</p>\n<p>随着美国人重返工作岗位，加之雇主努力留住员工，今年以来，失业救济申请人数呈下降趋势。</p>\n<p>物价上涨和新冠疫情继续加大企业经营及招聘活动难度。上月非农就业人数创下今年以来最小增幅，普遍出现劳动力短缺情况。</p>\n<p><img src=\"https://static.tigerbbs.com/474eb4abca6af4679c83ff8cd42f157c\" tg-width=\"720\" tg-height=\"479\" referrerpolicy=\"no-referrer\"></p>\n<p><b>尽管面临疫情挑战 标普仍预计明年石油需求将增长</b></p>\n<p><a href=\"https://laohu8.com/S/SPGI\">标普全球</a>普氏称，尽管全球仍在继续应对冠状病毒新变种，但明年石油需求仍将增长。</p>\n<p><a href=\"https://laohu8.com/S/SPGI\">标普全球</a>普氏的供应和生产主管Shin Kim在该公司2022年能源展望报告中表示，2022年消费增长的很大一部分将来自航油，以及市场对汽车燃料等其他石油产品的需求上升。</p>\n<p>“石油需求增长的基础稳固，”她说，预计明年的日需求量增幅在300万至640万桶之间。</p>\n<p>不过，能源市场的基调将取决于供应增长的步伐，经过两年的库存萎缩后，生产需要反弹才能满足需求。伊朗恢复供应将产生最大的影响。</p>\n<p>“如果我们不考虑伊朗，而且在其他地方发生重大供应中断，那就意味着真正的问题将是我们是否将试探100美元/桶的油价，” Kim说。</p>\n<p>她说，眼下市场正进入季节性油价疲软时期，但随着需求上升导致供应吃紧，油价5月份后应该会反弹。普氏预计，原油价格将在2022年中期左右回到每桶80美元的水平。</p>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 05:39 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复苏以来最低增幅\n\n\n4、美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n\n\n5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n\n\n6、尽管面临疫情挑战 标普仍预计明年石油需求...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190343645","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复苏以来最低增幅\n\n\n4、美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n\n\n5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n\n\n6、尽管面临疫情挑战 标普仍预计明年石油需求将增长\n\n\nIMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n国际货币基金组织（IMF）首席经济学家周四表示，各国央行没有空间维持宽松的货币政策和低利率，并警告说，新冠疫情的代价可能远高于预期。\nIMF首席经济学家Gita Gopinath表示，除了目前预计的12.5万亿美元损失之外，像奥密克戎（Omicron）这样更易传播的新冠变体可能会使全球经济再损失5.3万亿美元。\n“我们现在处于这样一个阶段，全球各国根本没有空间保持非常宽松的货币政策，将利率维持在极低的水平。我们看到全球各地的通胀压力都在积聚，”她说。\nGopinath补充说：“因此，想想这样一种情况，疫情可能会持续更长时间，供应中断时间会更长，从而带来通胀压力，然后我们面临着真正风险，即滞胀担忧。”\n\n美国商务部长称若不能解决芯片危机会造成毁灭性影响\n美国商务部长雷蒙多表示，如果国会不马上通过拜登政府旨在缓解芯片短缺问题的法案，对美国经济将产生“毁灭性”影响。\n“延后通过的后果再怎么说都不夸张，”雷蒙多周四接受采访时称。“如果不能在圣诞节前完成，就必须在1月完成，因为长期回避这个问题的后果对我们的经济和国家安全来说确实是毁灭性的，”她说道。\n雷蒙多一直在敦促国会通过《芯片法案》以提供520亿美元帮助计算机芯片制造商，缓解供应短缺局面。\n德克萨斯州共和党参议员John Cornyn周三表示，《芯片法案》可能要到2月才能通过。\n\n美国家庭净资产创疫后复苏以来最低增幅\n美国家庭净资产增速在第三季度降温，股市的暂时回撤抵消了房价上涨的财富效应。\n美联储周四发布的数据显示，在第二季度增加6.14万亿美元之后，家庭净资产在第三季度增加近2.4万亿美元，增幅为1.7%。虽然季度增量是疫情复苏中最小的一次。\n第三季度增长包括家庭房地产增值1.4万亿美元，但股票价值减少近3200亿美元。\n不过，并非所有人都从大流行期间的股价飙升和房地产热潮中受益。调查数据表明，仅有略多于一半的美国人持有股票。而对于租房居住的大约三分之一家庭来说，租金正在迅速上升。\n较高的储蓄水平仍然是家庭支出的一个重要来源，不过随着联邦政府刺激措施的减弱，储蓄有所下降。第三季度私人储蓄净额折年率增长2.84万亿美元，为2020年初以来最慢增速。\n\n美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n贝莱德的Gargi Chaudhuri预计周五的通胀数据将超过华尔街的预期，并建议投资者对冲更高的通胀。\n“我们可能会得到比市场定价略强一些的东西，”这位贝莱德iShares安硕美洲投资策略主管周四接受采访时表示。“我预计市场中的部分商品门类以及服务领域会更强劲，例如住房通胀。”\n通胀处于数十年来的最高水平。根据经济学家预测，周五的数据显示11月份通胀率达到6.8%，将是里根时代以来的最高水平，也是许多美国人有生以来遇到的最高通胀。\nChaudhuri表示，她预计2022年晚些时候通胀将放缓，而商品和服务价格将保持在疫情前水平之上。为了保护自己，投资者应该关注那些能够抵御通胀侵蚀回报的资产，例如“能够转嫁价格上涨的公司的股票”。\n\n美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n美国上周首次申请失业救济人数降至1969年以来最低水平，凸显出对数据进行季节性调整的难度。\n美国劳工部周四发布的数据显示，截至12月4日的一周，首次申领失业救济人数比前一周减少4.3万，至18.4万人。经济学家中值预期为22万人。\n此前两周该数据已经出现大幅下降，许多经济学家将其归因于假期前后季节性波动因素导致数据调整难度较大。未经调整的首次申领失业救济人数增加约64000人。\n随着美国人重返工作岗位，加之雇主努力留住员工，今年以来，失业救济申请人数呈下降趋势。\n物价上涨和新冠疫情继续加大企业经营及招聘活动难度。上月非农就业人数创下今年以来最小增幅，普遍出现劳动力短缺情况。\n\n尽管面临疫情挑战 标普仍预计明年石油需求将增长\n标普全球普氏称，尽管全球仍在继续应对冠状病毒新变种，但明年石油需求仍将增长。\n标普全球普氏的供应和生产主管Shin Kim在该公司2022年能源展望报告中表示，2022年消费增长的很大一部分将来自航油，以及市场对汽车燃料等其他石油产品的需求上升。\n“石油需求增长的基础稳固，”她说，预计明年的日需求量增幅在300万至640万桶之间。\n不过，能源市场的基调将取决于供应增长的步伐，经过两年的库存萎缩后，生产需要反弹才能满足需求。伊朗恢复供应将产生最大的影响。\n“如果我们不考虑伊朗，而且在其他地方发生重大供应中断，那就意味着真正的问题将是我们是否将试探100美元/桶的油价，” Kim说。\n她说，眼下市场正进入季节性油价疲软时期，但随着需求上升导致供应吃紧，油价5月份后应该会反弹。普氏预计，原油价格将在2022年中期左右回到每桶80美元的水平。","news_type":1},"isVote":1,"tweetType":1,"viewCount":778,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605143643,"gmtCreate":1639135033481,"gmtModify":1639135033729,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Looking forward [Grin]&nbsp;","listText":"Looking forward [Grin]&nbsp;","text":"Looking forward [Grin]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605143643","repostId":"1185363632","repostType":2,"repost":{"id":"1185363632","kind":"news","pubTimestamp":1639125824,"share":"https://www.laohu8.com/m/news/1185363632?lang=&edition=full","pubTime":"2021-12-10 16:43","market":"us","language":"en","title":"Will Apple Stock’s Rally Fizzle Out? Don’t Bet on It.","url":"https://stock-news.laohu8.com/highlight/detail?id=1185363632","media":"Barrons","summary":"Apple stock has been on a tear, and nothing seems to be able to knock it down for long. When I see t","content":"<p>Apple&nbsp;stock has been on a tear, and nothing seems to be able to knock it down for long. When I see that kind of acceleration, I usually start thinking it’s time to sell. The thing is, with Apple stock, it might not be.</p>\n<p>Apple stock (ticker: AAPL) has jumped 19% during the past month of trading, easily outperforming the&nbsp;Dow Jones Industrial Average’s 0.5% rise, the&nbsp;S&amp;P 500’s&nbsp;0.9% gain, and the&nbsp;Nasdaq Composite’s&nbsp;0.04% advance. It’s an amazing move when compared with the overall market, and how little bad news seems to hurt the stock. It even goes up when nearly everything else goes down.</p>\n<p>The gain also marks an acceleration for the stock. On Thursday, Apple was up 0.3% at $175.58, more than 15% above its 50-day moving average of $152.30. We looked at that hoping it would serve as a sell signal, but that’s not the case. During the past five years, Apple stock has gone on to advance 2% in the two weeks after trading 15% or higher above the 50-day moving average, and 3% in the month following it. The stock was higher one month later 28 out of 39 occurrences.</p>\n<p>Even if we use only the first instance of the stock rising 15% above the moving average—we eliminated any that occurred with five trading days of the first close—the stock performed OK, with shares gaining 0.9% two weeks after the first instance, and 9% during the month after.</p>\n<p>As much as we worry that Apple’s gains can’t continue in the long-run, at least based on recent history, Apple stock could have more room to run.</p>\n<p>That doesn’t mean Apple stock can just keep running in perpetuity. While the 15% threshold didn’t result in losses, a 20% threshold did. When that happened, Apple stock has dropped an average of 3% over the two weeks following the instance, and 2.9% month after.</p>\n<p>Apple stock can get too strong, after all. It’s just not there yet.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Will Apple Stock’s Rally Fizzle Out? Don’t Bet on It.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWill Apple Stock’s Rally Fizzle Out? Don’t Bet on It.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 16:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/apple-stock-price-buy-sell-rally-51639071310?mod=hp_LEADSUPP_3><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple stock has been on a tear, and nothing seems to be able to knock it down for long. When I see that kind of acceleration, I usually start thinking it’s time to sell. The thing is, with Apple stock...</p>\n\n<a href=\"https://www.barrons.com/articles/apple-stock-price-buy-sell-rally-51639071310?mod=hp_LEADSUPP_3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.barrons.com/articles/apple-stock-price-buy-sell-rally-51639071310?mod=hp_LEADSUPP_3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185363632","content_text":"Apple stock has been on a tear, and nothing seems to be able to knock it down for long. When I see that kind of acceleration, I usually start thinking it’s time to sell. The thing is, with Apple stock, it might not be.\nApple stock (ticker: AAPL) has jumped 19% during the past month of trading, easily outperforming the Dow Jones Industrial Average’s 0.5% rise, the S&P 500’s 0.9% gain, and the Nasdaq Composite’s 0.04% advance. It’s an amazing move when compared with the overall market, and how little bad news seems to hurt the stock. It even goes up when nearly everything else goes down.\nThe gain also marks an acceleration for the stock. On Thursday, Apple was up 0.3% at $175.58, more than 15% above its 50-day moving average of $152.30. We looked at that hoping it would serve as a sell signal, but that’s not the case. During the past five years, Apple stock has gone on to advance 2% in the two weeks after trading 15% or higher above the 50-day moving average, and 3% in the month following it. The stock was higher one month later 28 out of 39 occurrences.\nEven if we use only the first instance of the stock rising 15% above the moving average—we eliminated any that occurred with five trading days of the first close—the stock performed OK, with shares gaining 0.9% two weeks after the first instance, and 9% during the month after.\nAs much as we worry that Apple’s gains can’t continue in the long-run, at least based on recent history, Apple stock could have more room to run.\nThat doesn’t mean Apple stock can just keep running in perpetuity. While the 15% threshold didn’t result in losses, a 20% threshold did. When that happened, Apple stock has dropped an average of 3% over the two weeks following the instance, and 2.9% month after.\nApple stock can get too strong, after all. It’s just not there yet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":957,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605046996,"gmtCreate":1639096542813,"gmtModify":1639096543077,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605046996","repostId":"2190343645","repostType":2,"repost":{"id":"2190343645","kind":"news","pubTimestamp":1639085987,"share":"https://www.laohu8.com/m/news/2190343645?lang=&edition=full","pubTime":"2021-12-10 05:39","market":"hk","language":"zh","title":"外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了","url":"https://stock-news.laohu8.com/highlight/detail?id=2190343645","media":"新浪财经","summary":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复","content":"<p><b>全球财经媒体昨夜今晨共同关注的头条新闻主要有：</b></p>\n<blockquote>\n <b>1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险</b>\n</blockquote>\n<blockquote>\n <b>2、美国商务部长称若不能解决芯片危机会造成毁灭性影响</b>\n</blockquote>\n<blockquote>\n <b>3、美国家庭净资产创疫后复苏以来最低增幅</b>\n</blockquote>\n<blockquote>\n <b>4、美国CPI数据恐进一步攀升 <a href=\"https://laohu8.com/S/BLK\">贝莱德</a>：现在是时候对冲通胀了</b>\n</blockquote>\n<blockquote>\n <b>5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响</b>\n</blockquote>\n<blockquote>\n <b>6、尽管面临疫情挑战 标普仍预计明年石油需求将增长</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/171ee93eeb2ef6ad06cf1393d17fe165\" tg-width=\"720\" tg-height=\"461\" referrerpolicy=\"no-referrer\"></p>\n<p><b>IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险</b></p>\n<p>国际货币基金组织（IMF）首席经济学家周四表示，各国央行没有空间维持宽松的货币政策和低利率，并警告说，新冠疫情的代价可能远高于预期。</p>\n<p>IMF首席经济学家Gita Gopinath表示，除了目前预计的12.5万亿美元损失之外，像奥密克戎（Omicron）这样更易传播的新冠变体可能会使全球经济再损失5.3万亿美元。</p>\n<p>“我们现在处于这样一个阶段，全球各国根本没有空间保持非常宽松的货币政策，将利率维持在极低的水平。我们看到全球各地的通胀压力都在积聚，”她说。</p>\n<p>Gopinath补充说：“因此，想想这样一种情况，疫情可能会持续更长时间，供应中断时间会更长，从而带来通胀压力，然后我们面临着真正风险，即滞胀担忧。”</p>\n<p><img src=\"https://static.tigerbbs.com/5212ae28f04e24df1b80bd53b47e900c\" tg-width=\"720\" tg-height=\"541\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国商务部长称若不能解决芯片危机会造成毁灭性影响</b></p>\n<p>美国商务部长雷蒙多表示，如果国会不马上通过拜登政府旨在缓解芯片短缺问题的法案，对美国经济将产生“毁灭性”影响。</p>\n<p>“延后通过的后果再怎么说都不夸张，”雷蒙多周四接受采访时称。“如果不能在圣诞节前完成，就必须在1月完成，因为长期回避这个问题的后果对我们的经济和国家安全来说确实是毁灭性的，”她说道。</p>\n<p>雷蒙多一直在敦促国会通过《芯片法案》以提供520亿美元帮助计算机芯片制造商，缓解供应短缺局面。</p>\n<p>德克萨斯州共和党参议员John Cornyn周三表示，《芯片法案》可能要到2月才能通过。</p>\n<p><img src=\"https://static.tigerbbs.com/a6b793e107dcfc6eafc907b0b32a952c\" tg-width=\"720\" tg-height=\"406\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国家庭净资产创疫后复苏以来最低增幅</b></p>\n<p>美国家庭净资产增速在第三季度降温，股市的暂时回撤抵消了房价上涨的财富效应。</p>\n<p>美联储周四发布的数据显示，在第二季度增加6.14万亿美元之后，家庭净资产在第三季度增加近2.4万亿美元，增幅为1.7%。虽然季度增量是疫情复苏中最小的一次。</p>\n<p>第三季度增长包括家庭房地产增值1.4万亿美元，但股票价值减少近3200亿美元。</p>\n<p>不过，并非所有人都从大流行期间的股价飙升和房地产热潮中受益。调查数据表明，仅有略多于一半的美国人持有股票。而对于租房居住的大约三分之一家庭来说，租金正在迅速上升。</p>\n<p>较高的储蓄水平仍然是家庭支出的一个重要来源，不过随着联邦政府刺激措施的减弱，储蓄有所下降。第三季度私人储蓄净额折年率增长2.84万亿美元，为2020年初以来最慢增速。</p>\n<p><img src=\"https://static.tigerbbs.com/c01e6086ac39e2b3a4bd7ceb2827ad79\" tg-width=\"720\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国CPI数据恐进一步攀升 <a href=\"https://laohu8.com/S/BLK\">贝莱德</a>：现在是时候对冲通胀了</b></p>\n<p>贝莱德的Gargi Chaudhuri预计周五的通胀数据将超过华尔街的预期，并建议投资者对冲更高的通胀。</p>\n<p>“我们可能会得到比市场定价略强一些的东西，”这位贝莱德<a href=\"https://laohu8.com/S/EEME\">iShares</a>安硕美洲投资策略主管周四接受采访时表示。“我预计市场中的部分商品门类以及服务领域会更强劲，例如住房通胀。”</p>\n<p>通胀处于数十年来的最高水平。根据经济学家预测，周五的数据显示11月份通胀率达到6.8%，将是里根时代以来的最高水平，也是许多美国人有生以来遇到的最高通胀。</p>\n<p>Chaudhuri表示，她预计2022年晚些时候通胀将放缓，而商品和服务价格将保持在疫情前水平之上。为了保护自己，投资者应该关注那些能够抵御通胀侵蚀回报的资产，例如“能够转嫁价格上涨的公司的股票”。</p>\n<p><img src=\"https://static.tigerbbs.com/fcc456868080840479884603ed672cd3\" tg-width=\"720\" tg-height=\"481\" referrerpolicy=\"no-referrer\"></p>\n<p><b>美国上周首次申请失业救济人数降至52年最低 受季节性因素影响</b></p>\n<p>美国上周首次申请失业救济人数降至1969年以来最低水平，凸显出对数据进行季节性调整的难度。</p>\n<p>美国劳工部周四发布的数据显示，截至12月4日的一周，首次申领失业救济人数比前一周减少4.3万，至18.4万人。经济学家中值预期为22万人。</p>\n<p>此前两周该数据已经出现大幅下降，许多经济学家将其归因于假期前后季节性波动因素导致数据调整难度较大。未经调整的首次申领失业救济人数增加约64000人。</p>\n<p>随着美国人重返工作岗位，加之雇主努力留住员工，今年以来，失业救济申请人数呈下降趋势。</p>\n<p>物价上涨和新冠疫情继续加大企业经营及招聘活动难度。上月非农就业人数创下今年以来最小增幅，普遍出现劳动力短缺情况。</p>\n<p><img src=\"https://static.tigerbbs.com/474eb4abca6af4679c83ff8cd42f157c\" tg-width=\"720\" tg-height=\"479\" referrerpolicy=\"no-referrer\"></p>\n<p><b>尽管面临疫情挑战 标普仍预计明年石油需求将增长</b></p>\n<p><a href=\"https://laohu8.com/S/SPGI\">标普全球</a>普氏称，尽管全球仍在继续应对冠状病毒新变种，但明年石油需求仍将增长。</p>\n<p><a href=\"https://laohu8.com/S/SPGI\">标普全球</a>普氏的供应和生产主管Shin Kim在该公司2022年能源展望报告中表示，2022年消费增长的很大一部分将来自航油，以及市场对汽车燃料等其他石油产品的需求上升。</p>\n<p>“石油需求增长的基础稳固，”她说，预计明年的日需求量增幅在300万至640万桶之间。</p>\n<p>不过，能源市场的基调将取决于供应增长的步伐，经过两年的库存萎缩后，生产需要反弹才能满足需求。伊朗恢复供应将产生最大的影响。</p>\n<p>“如果我们不考虑伊朗，而且在其他地方发生重大供应中断，那就意味着真正的问题将是我们是否将试探100美元/桶的油价，” Kim说。</p>\n<p>她说，眼下市场正进入季节性油价疲软时期，但随着需求上升导致供应吃紧，油价5月份后应该会反弹。普氏预计，原油价格将在2022年中期左右回到每桶80美元的水平。</p>","source":"XLCJ","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n外媒头条：美国CPI恐再“爆表”！是时候对冲通胀了\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 05:39 北京时间&nbsp;&nbsp;&nbsp;<a href=https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复苏以来最低增幅\n\n\n4、美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n\n\n5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n\n\n6、尽管面临疫情挑战 标普仍预计明年石油需求...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/017a2d51f9605f643f552ed0e3997176","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-10/doc-ikyamrmy7981726.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190343645","content_text":"全球财经媒体昨夜今晨共同关注的头条新闻主要有：\n\n1、IMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n\n\n2、美国商务部长称若不能解决芯片危机会造成毁灭性影响\n\n\n3、美国家庭净资产创疫后复苏以来最低增幅\n\n\n4、美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n\n\n5、美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n\n\n6、尽管面临疫情挑战 标普仍预计明年石油需求将增长\n\n\nIMF首席经济学家：全球面临通胀压力和奥密克戎带来的风险\n国际货币基金组织（IMF）首席经济学家周四表示，各国央行没有空间维持宽松的货币政策和低利率，并警告说，新冠疫情的代价可能远高于预期。\nIMF首席经济学家Gita Gopinath表示，除了目前预计的12.5万亿美元损失之外，像奥密克戎（Omicron）这样更易传播的新冠变体可能会使全球经济再损失5.3万亿美元。\n“我们现在处于这样一个阶段，全球各国根本没有空间保持非常宽松的货币政策，将利率维持在极低的水平。我们看到全球各地的通胀压力都在积聚，”她说。\nGopinath补充说：“因此，想想这样一种情况，疫情可能会持续更长时间，供应中断时间会更长，从而带来通胀压力，然后我们面临着真正风险，即滞胀担忧。”\n\n美国商务部长称若不能解决芯片危机会造成毁灭性影响\n美国商务部长雷蒙多表示，如果国会不马上通过拜登政府旨在缓解芯片短缺问题的法案，对美国经济将产生“毁灭性”影响。\n“延后通过的后果再怎么说都不夸张，”雷蒙多周四接受采访时称。“如果不能在圣诞节前完成，就必须在1月完成，因为长期回避这个问题的后果对我们的经济和国家安全来说确实是毁灭性的，”她说道。\n雷蒙多一直在敦促国会通过《芯片法案》以提供520亿美元帮助计算机芯片制造商，缓解供应短缺局面。\n德克萨斯州共和党参议员John Cornyn周三表示，《芯片法案》可能要到2月才能通过。\n\n美国家庭净资产创疫后复苏以来最低增幅\n美国家庭净资产增速在第三季度降温，股市的暂时回撤抵消了房价上涨的财富效应。\n美联储周四发布的数据显示，在第二季度增加6.14万亿美元之后，家庭净资产在第三季度增加近2.4万亿美元，增幅为1.7%。虽然季度增量是疫情复苏中最小的一次。\n第三季度增长包括家庭房地产增值1.4万亿美元，但股票价值减少近3200亿美元。\n不过，并非所有人都从大流行期间的股价飙升和房地产热潮中受益。调查数据表明，仅有略多于一半的美国人持有股票。而对于租房居住的大约三分之一家庭来说，租金正在迅速上升。\n较高的储蓄水平仍然是家庭支出的一个重要来源，不过随着联邦政府刺激措施的减弱，储蓄有所下降。第三季度私人储蓄净额折年率增长2.84万亿美元，为2020年初以来最慢增速。\n\n美国CPI数据恐进一步攀升 贝莱德：现在是时候对冲通胀了\n贝莱德的Gargi Chaudhuri预计周五的通胀数据将超过华尔街的预期，并建议投资者对冲更高的通胀。\n“我们可能会得到比市场定价略强一些的东西，”这位贝莱德iShares安硕美洲投资策略主管周四接受采访时表示。“我预计市场中的部分商品门类以及服务领域会更强劲，例如住房通胀。”\n通胀处于数十年来的最高水平。根据经济学家预测，周五的数据显示11月份通胀率达到6.8%，将是里根时代以来的最高水平，也是许多美国人有生以来遇到的最高通胀。\nChaudhuri表示，她预计2022年晚些时候通胀将放缓，而商品和服务价格将保持在疫情前水平之上。为了保护自己，投资者应该关注那些能够抵御通胀侵蚀回报的资产，例如“能够转嫁价格上涨的公司的股票”。\n\n美国上周首次申请失业救济人数降至52年最低 受季节性因素影响\n美国上周首次申请失业救济人数降至1969年以来最低水平，凸显出对数据进行季节性调整的难度。\n美国劳工部周四发布的数据显示，截至12月4日的一周，首次申领失业救济人数比前一周减少4.3万，至18.4万人。经济学家中值预期为22万人。\n此前两周该数据已经出现大幅下降，许多经济学家将其归因于假期前后季节性波动因素导致数据调整难度较大。未经调整的首次申领失业救济人数增加约64000人。\n随着美国人重返工作岗位，加之雇主努力留住员工，今年以来，失业救济申请人数呈下降趋势。\n物价上涨和新冠疫情继续加大企业经营及招聘活动难度。上月非农就业人数创下今年以来最小增幅，普遍出现劳动力短缺情况。\n\n尽管面临疫情挑战 标普仍预计明年石油需求将增长\n标普全球普氏称，尽管全球仍在继续应对冠状病毒新变种，但明年石油需求仍将增长。\n标普全球普氏的供应和生产主管Shin Kim在该公司2022年能源展望报告中表示，2022年消费增长的很大一部分将来自航油，以及市场对汽车燃料等其他石油产品的需求上升。\n“石油需求增长的基础稳固，”她说，预计明年的日需求量增幅在300万至640万桶之间。\n不过，能源市场的基调将取决于供应增长的步伐，经过两年的库存萎缩后，生产需要反弹才能满足需求。伊朗恢复供应将产生最大的影响。\n“如果我们不考虑伊朗，而且在其他地方发生重大供应中断，那就意味着真正的问题将是我们是否将试探100美元/桶的油价，” Kim说。\n她说，眼下市场正进入季节性油价疲软时期，但随着需求上升导致供应吃紧，油价5月份后应该会反弹。普氏预计，原油价格将在2022年中期左右回到每桶80美元的水平。","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602701017,"gmtCreate":1639062728669,"gmtModify":1639062802569,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"[Cry]&nbsp;","listText":"[Cry]&nbsp;","text":"[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602701017","repostId":"1196130142","repostType":4,"repost":{"id":"1196130142","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639062546,"share":"https://www.laohu8.com/m/news/1196130142?lang=&edition=full","pubTime":"2021-12-09 23:09","market":"us","language":"en","title":"Grab stock dropped more than 6% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1196130142","media":"Tiger Newspress","summary":"Grab Holdings stock dropped more than 6% in morning trading.","content":"<p>Grab Holdings stock dropped more than 6% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/f1c84529a60ffcf4e7ba53b126b147d9\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab stock dropped more than 6% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab stock dropped more than 6% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Grab Holdings stock dropped more than 6% in morning trading.</p>\n<p><img src=\"https://static.tigerbbs.com/f1c84529a60ffcf4e7ba53b126b147d9\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196130142","content_text":"Grab Holdings stock dropped more than 6% in morning trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608803786,"gmtCreate":1638673598357,"gmtModify":1638673598522,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608803786","repostId":"1162832222","repostType":4,"repost":{"id":"1162832222","kind":"news","pubTimestamp":1638544942,"share":"https://www.laohu8.com/m/news/1162832222?lang=&edition=full","pubTime":"2021-12-03 23:22","market":"us","language":"en","title":"China’s Asymchem Said to Guide Listing Price at HK$388","url":"https://stock-news.laohu8.com/highlight/detail?id=1162832222","media":"Bloomberg","summary":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kon","content":"<ul>\n <li>Shenzhen-listed Asymchem is selling 18.4 million shares</li>\n <li>Asymchem will raise $917 million in Hong Kong listing</li>\n</ul>\n<p>Chinese drug manufacturer&nbsp;Asymchem Laboratories Tianjin Co.&nbsp;is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.</p>\n<p>The Tianjin-based pharmaceutical company, which is already&nbsp;listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.</p>\n<p>An external representative for the company couldn’t immediately respond to a request for comment.</p>\n<p>The company&nbsp;marketed&nbsp;about 18.4 million shares for between HK$350 and HK$410 each.</p>\n<p>Asymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s&nbsp;prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.</p>\n<p>The shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc.&nbsp;and&nbsp;Citic Securities Co.&nbsp;are joint sponsors for the share sale.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China’s Asymchem Said to Guide Listing Price at HK$388</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina’s Asymchem Said to Guide Listing Price at HK$388\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-03 23:22 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"06821":"凯莱英"},"source_url":"https://www.bloomberg.com/news/articles/2021-12-03/china-s-asymchem-said-to-guide-pricing-h-k-share-sale-at-hk-388?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162832222","content_text":"Shenzhen-listed Asymchem is selling 18.4 million shares\nAsymchem will raise $917 million in Hong Kong listing\n\nChinese drug manufacturer Asymchem Laboratories Tianjin Co. is telling prospective investors it plans to price its Hong Kong listing at HK$388 per share, according to people familiar with the matter.\nThe Tianjin-based pharmaceutical company, which is already listed in Shenzhen, will raise HK$7.15 billion ($917 million) at that price, the people said, asking not to be identified as the information isn’t public. The prospective price represents a 33.7% discount to Asymchem’s last close in Shenzhen of 478.60 yuan.\nAn external representative for the company couldn’t immediately respond to a request for comment.\nThe company marketed about 18.4 million shares for between HK$350 and HK$410 each.\nAsymchem provides solutions to the pharmaceutical industry through the drug development and manufacturing process, according to the offering’s prospectus. The company reported 429.3 million yuan ($67 million) in net income in the six months ended June 30, a 37% increase over the same period last year.\nThe shares are expected to begin trading on Dec. 10.Goldman Sachs Group Inc. and Citic Securities Co. are joint sponsors for the share sale.","news_type":1},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608803888,"gmtCreate":1638673524252,"gmtModify":1638673524416,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608803888","repostId":"1158981658","repostType":4,"repost":{"id":"1158981658","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638545456,"share":"https://www.laohu8.com/m/news/1158981658?lang=&edition=full","pubTime":"2021-12-03 23:30","market":"us","language":"en","title":"Tesla's Musk over halfway through his pledge with nearly $11 bln stake sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1158981658","media":"Reuters","summary":"Dec 3  - Tesla Inc Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million","content":"<p>Dec 3 (Reuters) - Tesla Inc&nbsp;Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.</p>\n<p>He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.</p>\n<p>Here is a string of transactions he has done:</p>\n<table>\n <tbody>\n  <tr>\n   <td>DATE</td>\n   <td>SHARES ACQUIRED</td>\n   <td>SHARES SOLD</td>\n   <td>GROSS PROCEEDS</td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td>2.2 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$1.10 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 9</td>\n   <td></td>\n   <td>3.1 mln</td>\n   <td>$3.35 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 10</td>\n   <td></td>\n   <td>500,000</td>\n   <td>$527.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 11</td>\n   <td></td>\n   <td>639,737</td>\n   <td>$687.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 12</td>\n   <td></td>\n   <td>1.2 mln</td>\n   <td>$1.24 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$930.7 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$973.4 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 23</td>\n   <td>2.15 mln</td>\n   <td>934,091</td>\n   <td>$1.05 bln</td>\n  </tr>\n  <tr>\n   <td>DEC. 2</td>\n   <td>2.1 mln</td>\n   <td>934,091</td>\n   <td>$1.01 bln</td>\n  </tr>\n  <tr>\n   <td>Total</td>\n   <td>10.7 mln</td>\n   <td>10.1 mln</td>\n   <td>$10.87 bln</td>\n  </tr>\n </tbody>\n</table>\n<p><b>HOW DID MUSK SELL?</b></p>\n<p>Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.</p>\n<p>The tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.</p>\n<p>Following a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla's Musk over halfway through his pledge with nearly $11 bln stake sale</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla's Musk over halfway through his pledge with nearly $11 bln stake sale\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 23:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 3 (Reuters) - Tesla Inc&nbsp;Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.</p>\n<p>He has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.</p>\n<p>Here is a string of transactions he has done:</p>\n<table>\n <tbody>\n  <tr>\n   <td>DATE</td>\n   <td>SHARES ACQUIRED</td>\n   <td>SHARES SOLD</td>\n   <td>GROSS PROCEEDS</td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td>2.2 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 8</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$1.10 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 9</td>\n   <td></td>\n   <td>3.1 mln</td>\n   <td>$3.35 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 10</td>\n   <td></td>\n   <td>500,000</td>\n   <td>$527.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 11</td>\n   <td></td>\n   <td>639,737</td>\n   <td>$687.3 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 12</td>\n   <td></td>\n   <td>1.2 mln</td>\n   <td>$1.24 bln</td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 15</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$930.7 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td>2.1 mln</td>\n   <td></td>\n   <td></td>\n  </tr>\n  <tr>\n   <td>NOV. 16</td>\n   <td></td>\n   <td>934,091</td>\n   <td>$973.4 mln</td>\n  </tr>\n  <tr>\n   <td>NOV. 23</td>\n   <td>2.15 mln</td>\n   <td>934,091</td>\n   <td>$1.05 bln</td>\n  </tr>\n  <tr>\n   <td>DEC. 2</td>\n   <td>2.1 mln</td>\n   <td>934,091</td>\n   <td>$1.01 bln</td>\n  </tr>\n  <tr>\n   <td>Total</td>\n   <td>10.7 mln</td>\n   <td>10.1 mln</td>\n   <td>$10.87 bln</td>\n  </tr>\n </tbody>\n</table>\n<p><b>HOW DID MUSK SELL?</b></p>\n<p>Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.</p>\n<p>The tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.</p>\n<p>Following a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158981658","content_text":"Dec 3 (Reuters) - Tesla Inc Chief Executive Elon Musk has sold nearly $11 billion worth of shares since the world's richest person polled Twitter users about offloading 10% of his stake in the electric-car maker.\nHe has sold a combined 10.1 million shares, which is over half of the stake that he had pledged to sell, and has acquired 10.7 million shares by exercising options, since Nov. 8.\nHere is a string of transactions he has done:\n\n\n\nDATE\nSHARES ACQUIRED\nSHARES SOLD\nGROSS PROCEEDS\n\n\nNOV. 8\n2.2 mln\n\n\n\n\nNOV. 8\n\n934,091\n$1.10 bln\n\n\nNOV. 9\n\n3.1 mln\n$3.35 bln\n\n\nNOV. 10\n\n500,000\n$527.3 mln\n\n\nNOV. 11\n\n639,737\n$687.3 mln\n\n\nNOV. 12\n\n1.2 mln\n$1.24 bln\n\n\nNOV. 15\n2.1 mln\n\n\n\n\nNOV. 15\n\n934,091\n$930.7 mln\n\n\nNOV. 16\n2.1 mln\n\n\n\n\nNOV. 16\n\n934,091\n$973.4 mln\n\n\nNOV. 23\n2.15 mln\n934,091\n$1.05 bln\n\n\nDEC. 2\n2.1 mln\n934,091\n$1.01 bln\n\n\nTotal\n10.7 mln\n10.1 mln\n$10.87 bln\n\n\n\nHOW DID MUSK SELL?\nMusk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed. He owned a combination of about 244 million shares through his trust and stock options, bringing his stake in Tesla to about 23% as of June 30. It included 170 million shares held by his trust.\nThe tweet was vague. Musk did not outline if he was intending to offload 10% of his shares he indirectly owned through the trust or if his stock options were also part of the deal.\nFollowing a flurry of options exercise, Musk still has an option to buy about 10 million more shares at $6.24 each, which expires in August next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608177911,"gmtCreate":1638673161412,"gmtModify":1638673161579,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608177911","repostId":"2188853578","repostType":4,"repost":{"id":"2188853578","kind":"news","pubTimestamp":1638567812,"share":"https://www.laohu8.com/m/news/2188853578?lang=&edition=full","pubTime":"2021-12-04 05:43","market":"us","language":"en","title":"Wall St ends lower on Omicron worries, Fed taper angst","url":"https://stock-news.laohu8.com/highlight/detail?id=2188853578","media":"Reuters","summary":"Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the de","content":"<p>Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of support all while they grappled with uncertainty around the Omicron coronavirus variant.</p>\n<p>After opening higher, Wall Street spent the rest of the session in the doldrums and an elevated volatility index highlighted investor anxiety.</p>\n<p>The Labor Department's report, ahead of the session's open, showed that while nonfarm job growth rose less than expected in November, the unemployment rate dropped to 4.2%, its lowest since February 2020, and wages increased.</p>\n<p>Separately, a measure of U.S. services industry activity hit a record high in November.</p>\n<p>Both sets of data appeared to influence investor expectations for the Fed's next move towards tightening its policy. Fed Chair Jerome Powell said this week that the central bank will consider a faster wind-down of its bond-buying program, prompting speculation that interest rate hikes would also be brought forward.</p>\n<p>\"There's not enough in the jobs report to dissuade the Fed from accelerating the taper and (it) leaves the door open for a quicker rate hike than the market might have been anticipating,\" said Steve Sosnick, chief strategist at Interactive Brokers.</p>\n<p>On top of this he pointed to concerns that the Omicron variant appeared to be spreading faster than Delta, the last most prevalent version of COVID-19.</p>\n<p>The number of countries reporting Omicron cases kept rising on Friday but there was still little clarity on the severity of the disease or the level of protection provided by existing COVID-19 vaccines.</p>\n<p>The Dow Jones Industrial Average fell 59.71 points, or 0.17%, to 34,580.08, the S&amp;P 500 lost 38.67 points, or 0.84%, to 4,538.43 and the Nasdaq Composite dropped 295.85 points, or 1.92%, to 15,085.47.</p>\n<p>The S&amp;P, the Dow and the Nasdaq all registered declines for a week in which they swung wildly from day to day as investors reacted to Omicron news and Powell's comments.</p>\n<p>The S&amp;P's decline of 1.2% was its second weekly decline in a row while the Nasdaq fell 2.62%, also its second straight week of losses. The Dow dropped 0.92% in its fourth consecutive weekly decline.</p>\n<p>In a clear indication of investor nerves, Wall Street's fear gauge, the CBOE Market Volatility index, went above 35, in afternoon trading, for the first time since late January. It pared some gains however to close up 9.7 points at 30.67.</p>\n<p>Meanwhile the S&amp;P sector outperformers were defensive sectors consumer staples, closing up 1.4% and utilities, adding 1%, followed by healthcare, which climbed 0.25%.</p>\n<p>By the end of the session, consumer discretionary, down 1.8%, was the biggest loser, followed by technology , which fell 1.65%.</p>\n<p>Decliners included heavyweights such as Tesla, down 6%, and Nvidia, down 4% and both Apple Inc and Microsoft losing more than 1%.</p>\n<p>\"It's hard to argue that stocks with such huge valuations are defensive,\" said Interactive Brokers' Sosnick.</p>\n<p>And with large cap technology stocks having avoided a recent deterioration in the broader markets, Sosnick said: \"That's catching up to those stocks.\"</p>\n<p>The economically sensitive Dow fell less than its peers during the session while other cyclical sectors like industrials , materials also outperformed.</p>\n<p>DocuSign Inc closed down 42% after the electronic signature solutions firm forecast downbeat fourth-quarter revenue.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 2.68-to-1 ratio; on Nasdaq, a 3.39-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted 11 new 52-week highs and six new lows; the Nasdaq Composite recorded 15 new highs and 682 new lows.</p>\n<p>On U.S. exchanges 13.8 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions. (Reporting by Sinéad Carew in New York; Devik Jain, Anisha Sircar and Sruthi Shankar in Bengaluru; Editing by Marguerita Choy and Maju Samuel)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall St ends lower on Omicron worries, Fed taper angst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall St ends lower on Omicron worries, Fed taper angst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-04 05:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of...</p>\n\n<a href=\"https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","BK4079":"房地产服务","BK4539":"次新股",".DJI":"道琼斯","COMP":"Compass, Inc.",".IXIC":"NASDAQ Composite"},"source_url":"https://finance.yahoo.com/news/us-stocks-wall-st-ends-214332016.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2188853578","content_text":"Dec 3 (Reuters) - Wall Street's major indexes closed lower on Friday, with the Nasdaq leading the declines as investors bet that a strong jobs report would not slow the Federal Reserve's withdrawal of support all while they grappled with uncertainty around the Omicron coronavirus variant.\nAfter opening higher, Wall Street spent the rest of the session in the doldrums and an elevated volatility index highlighted investor anxiety.\nThe Labor Department's report, ahead of the session's open, showed that while nonfarm job growth rose less than expected in November, the unemployment rate dropped to 4.2%, its lowest since February 2020, and wages increased.\nSeparately, a measure of U.S. services industry activity hit a record high in November.\nBoth sets of data appeared to influence investor expectations for the Fed's next move towards tightening its policy. Fed Chair Jerome Powell said this week that the central bank will consider a faster wind-down of its bond-buying program, prompting speculation that interest rate hikes would also be brought forward.\n\"There's not enough in the jobs report to dissuade the Fed from accelerating the taper and (it) leaves the door open for a quicker rate hike than the market might have been anticipating,\" said Steve Sosnick, chief strategist at Interactive Brokers.\nOn top of this he pointed to concerns that the Omicron variant appeared to be spreading faster than Delta, the last most prevalent version of COVID-19.\nThe number of countries reporting Omicron cases kept rising on Friday but there was still little clarity on the severity of the disease or the level of protection provided by existing COVID-19 vaccines.\nThe Dow Jones Industrial Average fell 59.71 points, or 0.17%, to 34,580.08, the S&P 500 lost 38.67 points, or 0.84%, to 4,538.43 and the Nasdaq Composite dropped 295.85 points, or 1.92%, to 15,085.47.\nThe S&P, the Dow and the Nasdaq all registered declines for a week in which they swung wildly from day to day as investors reacted to Omicron news and Powell's comments.\nThe S&P's decline of 1.2% was its second weekly decline in a row while the Nasdaq fell 2.62%, also its second straight week of losses. The Dow dropped 0.92% in its fourth consecutive weekly decline.\nIn a clear indication of investor nerves, Wall Street's fear gauge, the CBOE Market Volatility index, went above 35, in afternoon trading, for the first time since late January. It pared some gains however to close up 9.7 points at 30.67.\nMeanwhile the S&P sector outperformers were defensive sectors consumer staples, closing up 1.4% and utilities, adding 1%, followed by healthcare, which climbed 0.25%.\nBy the end of the session, consumer discretionary, down 1.8%, was the biggest loser, followed by technology , which fell 1.65%.\nDecliners included heavyweights such as Tesla, down 6%, and Nvidia, down 4% and both Apple Inc and Microsoft losing more than 1%.\n\"It's hard to argue that stocks with such huge valuations are defensive,\" said Interactive Brokers' Sosnick.\nAnd with large cap technology stocks having avoided a recent deterioration in the broader markets, Sosnick said: \"That's catching up to those stocks.\"\nThe economically sensitive Dow fell less than its peers during the session while other cyclical sectors like industrials , materials also outperformed.\nDocuSign Inc closed down 42% after the electronic signature solutions firm forecast downbeat fourth-quarter revenue.\nDeclining issues outnumbered advancing ones on the NYSE by a 2.68-to-1 ratio; on Nasdaq, a 3.39-to-1 ratio favored decliners.\nThe S&P 500 posted 11 new 52-week highs and six new lows; the Nasdaq Composite recorded 15 new highs and 682 new lows.\nOn U.S. exchanges 13.8 billion shares changed hands compared with the 11.52 billion average for the last 20 sessions. (Reporting by Sinéad Carew in New York; Devik Jain, Anisha Sircar and Sruthi Shankar in Bengaluru; Editing by Marguerita Choy and Maju Samuel)","news_type":1},"isVote":1,"tweetType":1,"viewCount":565,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608149709,"gmtCreate":1638670858416,"gmtModify":1638670858569,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/608149709","repostId":"2188578706","repostType":4,"repost":{"id":"2188578706","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638577500,"share":"https://www.laohu8.com/m/news/2188578706?lang=&edition=full","pubTime":"2021-12-04 08:25","market":"us","language":"en","title":"DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'","url":"https://stock-news.laohu8.com/highlight/detail?id=2188578706","media":"Dow Jones","summary":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pande","content":"<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDocuSign stock craters to worst day on record after 'one of the biggest SaaS whiffs in recent memory'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 08:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down</p>\n<p>DocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.</p>\n<p>Shares of DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"</p>\n<p>The stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&amp;P 500 index has rallied 21% this year after climbing 16% last year.</p>\n<p>The company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"</p>\n<p>Citi Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.</p>\n<p>\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.</p>\n<p>Radke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.</p>\n<p>Evercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"</p>\n<p>But the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"</p>\n<p>While he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"</p>\n<p>He cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.</p>\n<p>DocuSign shares are off roughly 52% from their September closing high of $310.05.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4528":"SaaS概念","DOCU":"Docusign"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188578706","content_text":"Electronic-signature company drops more than 40%, shedding nearly $20 billion of market cap as pandemic boom in e-signature sales slows down\nDocuSign Inc. emerged as a hot pandemic stock play last year as it benefited from the need for digital contract tools, but the company lost more than 40% of its valuation Friday after suggesting the pandemic-induced demand boom is waning.\nShares of DocuSign $(DOCU)$ fell 42.2% Friday, by far their steepest single-day percentage decline on record, wiping away roughly $19.4 billion worth of market capitalization. DocuSign issued earnings Thursday evening with a disappointing billings outlook, and Chief Executive Dan Springer called out a \"return to more normalized buying patterns\" following a stretch of \"accelerated growth.\"\nThe stock nearly tripled in 2020, pushing its market cap higher than $40 billion, but is now down 39.2% this year. In comparison, the S&P 500 index has rallied 21% this year after climbing 16% last year.\nThe company's report served as \"a good reminder that even outstanding companies take their proverbial eye off the sales ball,\" Needham analyst Scott Berg wrote in a note downgrading DocuSign's stock to hold from buy. While DocuSign announced that it would be changing some elements of its sales organization, Berg said he has found that \"fixing these sales issues often requires several quarters.\"\nCiti Research analyst Tyler Radke wrote that DocuSign delivered \"one of the biggest SaaS [software-as-a-service] whiffs in recent memory with total billings growth of 28% significantly below [the] 34% guide\" during the fiscal third quarter. DocuSign's billings outlook for the fiscal fourth quarter was 22% at the midpoint, which came in significantly below the 32% consensus figure Radke cited in his note to clients.\n\"With a largely resilient performance vs [work-from-home] peers over the last two quarters, we are surprised that DOCU is seeing significant customer behavior/execution issues cropping up now, and in this magnitude,\" he continued.\nRadke called the report a \"thesis shifter,\" though he kept his buy rating on the stock, arguing that DocuSign has a \"first-mover advantage\" in its domain and that there are \"few signs\" that people are shifting back to manual agreements. He cut his target price to $231 from $389.\nEvercore ISI analyst Kirk Materne wrote that while DocuSign faced difficult comparisons in its most recent quarter, the company \"simply misread the market in terms of demand and that led to a faster than expected deceleration in billings growth.\"\nBut the stock's sharp move downward indicates that \"the damage is essentially done as it relates to the quarter,\" he wrote. Further, after speaking with DocuSign's management team, Materne believes that DocuSign's fiscal fourth-quarter billing outlook \"assumes no improvement in demand [generation] vs. 3Q, which could prove conservative.\"\nWhile he called the stock's selloff \"a bit overdone,\" Materne admitted that \"the reality is this stock just went from a story where investors were thinking about durable growth being in the 30%'s to being in the 20%'s and that's going to create a pretty material de-rate.\"\nHe cut his price target to $200 from $320, writing that \"until DOCU can show that it can generate, not just fulfill, demand on a regular basis, the multiple is capped.\" Materne kept an outperform rating on the stock, citing the long-term potential of e-signature technology especially in markets like government where DocuSign is \"very early\" in its penetration.\nDocuSign shares are off roughly 52% from their September closing high of $310.05.","news_type":1},"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608167563,"gmtCreate":1638668161925,"gmtModify":1638668162078,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608167563","repostId":"2188057871","repostType":4,"repost":{"id":"2188057871","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638580800,"share":"https://www.laohu8.com/m/news/2188057871?lang=&edition=full","pubTime":"2021-12-04 09:20","market":"us","language":"en","title":"Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2188057871","media":"Dow Jones","summary":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic bo","content":"<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4567":"ESG概念","BK4527":"明星科技股","BK4534":"瑞士信贷持仓","BK4528":"SaaS概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4023":"应用软件","ADBE":"Adobe","BK4554":"元宇宙及AR概念","BK4566":"资本集团","DOCU":"Docusign"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188057871","content_text":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic boom was slowing down\nShares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.\nDocuSign $(DOCU)$ Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.\nSome of that investor fear seemed to transfer over to Adobe $(ADBE)$, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.\nThe decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"\n\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.\nAdobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"\nWhile other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.\nAdobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.\nShares of Adobe were up 86% since March 2020 as of Thursday's close.","news_type":1},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608164347,"gmtCreate":1638667895490,"gmtModify":1638667895731,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608164347","repostId":"2188787815","repostType":4,"isVote":1,"tweetType":1,"viewCount":546,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608166625,"gmtCreate":1638667610618,"gmtModify":1638667610788,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608166625","repostId":"1140678193","repostType":4,"isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608168615,"gmtCreate":1638667512460,"gmtModify":1638667512582,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608168615","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://www.laohu8.com/m/news/1174181873?lang=&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p>\n<p>Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p>\n<p>Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p>\n<p>Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p>\n<p>Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-04 08:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REFI":"Chicago Atlantic Real Estate Finance, Inc.","HCP":"HashiCorp, Inc.","NU":"Nu Holdings Ltd."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1},"isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":147753795,"gmtCreate":1626392727417,"gmtModify":1633927254686,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/147753795","repostId":"1140595356","repostType":4,"repost":{"id":"1140595356","kind":"news","pubTimestamp":1626387586,"share":"https://www.laohu8.com/m/news/1140595356?lang=&edition=full","pubTime":"2021-07-16 06:19","market":"us","language":"en","title":"Why Moderna Stock Is Hitting Another Record High Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1140595356","media":"Motley Fool","summary":"The vaccine stock benefited from two positive developments.\n\nKey Points\n\nA Wall Street analyst raise","content":"<blockquote>\n The vaccine stock benefited from two positive developments.\n</blockquote>\n<p><b>Key Points</b></p>\n<ul>\n <li>A Wall Street analyst raised his price target for Moderna.</li>\n <li>A top European official also stated that a recommendation on authorization for Moderna's COVID-19 vaccine would probably be made by late next week.</li>\n</ul>\n<p><b>What happened</b></p>\n<p>Shares of<b>Moderna</b>(NASDAQ:MRNA)were jumping 4.3% as of 11:10 a.m. EDT on Thursday, hitting another record high for the stock. The bump came after Michael Yee, an analyst at<b>Jefferies</b>, increased his price target on the stock from $170 to $250.</p>\n<p>Also, Dr. Marco Cavaleri, the European Medicines Agency (EMA) head of biological health threats and vaccines strategy, stated in a press conference that a committee would likely finalize a decision on recommending authorization for Moderna's COVID-19 vaccine in children by the end of next week.</p>\n<p><b>So what</b></p>\n<p>Jefferies' higher price target for thevaccine stockreflected expectations of increased sales for Moderna's COVID-19 vaccine this year. Yee now looks for the company to up its full-year revenue guidance to $21 billion. It previously projected sales of $19.2 billion.</p>\n<p>The EMA's decision on authorization of the vaccine in immunizing children ages 12 to 17 could play a key role in driving higher sales. Although there are many more adults in the European Union than children, the pediatric market presents a big opportunity for the company.</p>\n<p>Neither of these news items, however, were compelling reasons for Moderna's shares to move higher. Jefferies' price target is actually lower than its current share price. Also, Cavaleri's comments about the pending decision by an expert committee didn't provide any hints as to what the recommendation would be.</p>\n<p><b>Now what</b></p>\n<p>The most important thing to watch with Moderna in the near term isn't the EMA committee announcement next week. Instead, it's the company's second-quarter update scheduled for Aug. 5. Moderna is likely to boost its full-year sales outlook in that update.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Moderna Stock Is Hitting Another Record High Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Moderna Stock Is Hitting Another Record High Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 06:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/15/why-moderna-stock-is-hitting-another-record-high-t/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine stock benefited from two positive developments.\n\nKey Points\n\nA Wall Street analyst raised his price target for Moderna.\nA top European official also stated that a recommendation on ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/15/why-moderna-stock-is-hitting-another-record-high-t/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/07/15/why-moderna-stock-is-hitting-another-record-high-t/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1140595356","content_text":"The vaccine stock benefited from two positive developments.\n\nKey Points\n\nA Wall Street analyst raised his price target for Moderna.\nA top European official also stated that a recommendation on authorization for Moderna's COVID-19 vaccine would probably be made by late next week.\n\nWhat happened\nShares ofModerna(NASDAQ:MRNA)were jumping 4.3% as of 11:10 a.m. EDT on Thursday, hitting another record high for the stock. The bump came after Michael Yee, an analyst atJefferies, increased his price target on the stock from $170 to $250.\nAlso, Dr. Marco Cavaleri, the European Medicines Agency (EMA) head of biological health threats and vaccines strategy, stated in a press conference that a committee would likely finalize a decision on recommending authorization for Moderna's COVID-19 vaccine in children by the end of next week.\nSo what\nJefferies' higher price target for thevaccine stockreflected expectations of increased sales for Moderna's COVID-19 vaccine this year. Yee now looks for the company to up its full-year revenue guidance to $21 billion. It previously projected sales of $19.2 billion.\nThe EMA's decision on authorization of the vaccine in immunizing children ages 12 to 17 could play a key role in driving higher sales. Although there are many more adults in the European Union than children, the pediatric market presents a big opportunity for the company.\nNeither of these news items, however, were compelling reasons for Moderna's shares to move higher. Jefferies' price target is actually lower than its current share price. Also, Cavaleri's comments about the pending decision by an expert committee didn't provide any hints as to what the recommendation would be.\nNow what\nThe most important thing to watch with Moderna in the near term isn't the EMA committee announcement next week. Instead, it's the company's second-quarter update scheduled for Aug. 5. Moderna is likely to boost its full-year sales outlook in that update.","news_type":1},"isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":840115055,"gmtCreate":1635605463177,"gmtModify":1635605463332,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/840115055","repostId":"2179223698","repostType":4,"repost":{"id":"2179223698","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1635578545,"share":"https://www.laohu8.com/m/news/2179223698?lang=&edition=full","pubTime":"2021-10-30 15:22","market":"hk","language":"en","title":"Biden to push G20 energy producers to boost capacity, ease price pressures","url":"https://stock-news.laohu8.com/highlight/detail?id=2179223698","media":"Reuters","summary":"ROME, Oct 30 (Reuters) - U.S. President Joe Biden on Saturday will urge major G20 energy producers w","content":"<p>ROME, Oct 30 (Reuters) - U.S. President Joe Biden on Saturday will urge major G20 energy producers with spare capacity to boost production to ensure a stronger global economic recovery, a senior administration official said ahead of a summit bringing together leaders of the world's largest economies.</p>\n<p>Biden and other Group of 20 leaders are slated to discuss efforts to end the COVID-19 pandemic and agree on a new task force to improve coordination and planning to prevent the next <a href=\"https://laohu8.com/S/AONE.U\">one</a>. They also expect to endorse an agreement backed by more than 130 countries to establish a new global minimum tax.</p>\n<p>But members are divided on other issues. With oil and gas prices surging, some energy-producing countries such as Russia and Saudi Arabia have not boosted output enough to satisfy countries that are largely consumers of energy and worry about energy shortages and inflation.</p>\n<p>Biden's top advisers have voiced concerns about energy suppliers not boosting production enough to meet surging demand.</p>\n<p>Rocketing natural gas prices, with the European benchmark up almost 600% this year, have been fuelled by low inventories and surging demand as economies recover from the COVID-19 crisis.</p>\n<p>Biden's national security adviser Jake Sullivan raised similar issues</p>\n<p>during a visit to Brussels this month, singling out Russia for its \"history of using energy as a tool of coercion, as a political weapon.\"</p>\n<p>Russia, a major natural gas supplier to Europe, and its energy giant Gazprom are being urged to do more to ease prices in the spot market.</p>\n<p>\"It's a delicate time in the global economy, and what's important is that global energy supplies keep up with global energy demand,\" the senior administration official said.</p>\n<p>\"There are major energy producers that have spare capacity, and we're encouraging them to use to ensure a stronger, more sustainable recovery across the world,\" the official said, without naming any specific countries.</p>\n<p>The official said G20 leaders would not specifically target the Organization of the Petroleum Exporting Countries (OPEC), which includes Saudi Arabia, or set any targets for energy production.</p>\n<p>Russian President Vladimir Putin will not attend the summit in person, but is expected to participate virtually.</p>\n<p>Comments from Russian Deputy Prime Minister Alexander Novak earlier this month sparked fresh tensions over the Nord Stream 2 undersea gas pipeline, which Washington has long opposed and which is now awaiting clearance from a German regulator.</p>\n<p>Novak said clearing the pipeline could help ease shortfalls, sparking concerns that Russia has failed to boost its production of gas - now delivered via land-based pipelines - precisely to put pressure on Europe to approve Nord Stream 2.</p>\n<p>During their talks on the economy, G20 leaders will also back an agreement reached by more than 130 countries on a global minimum corporate tax of 15% that will reshape the world economy and could result in some $60 billion in additional tax revenues per year for the United States alone, the official said.</p>\n<p>\"The deal is a testament to American diplomacy and leadership,\" the official said, noting that Biden and Treasury Secretary Janet Yellen had worked hard to secure the agreement.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biden to push G20 energy producers to boost capacity, ease price pressures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiden to push G20 energy producers to boost capacity, ease price pressures\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-30 15:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ROME, Oct 30 (Reuters) - U.S. President Joe Biden on Saturday will urge major G20 energy producers with spare capacity to boost production to ensure a stronger global economic recovery, a senior administration official said ahead of a summit bringing together leaders of the world's largest economies.</p>\n<p>Biden and other Group of 20 leaders are slated to discuss efforts to end the COVID-19 pandemic and agree on a new task force to improve coordination and planning to prevent the next <a href=\"https://laohu8.com/S/AONE.U\">one</a>. They also expect to endorse an agreement backed by more than 130 countries to establish a new global minimum tax.</p>\n<p>But members are divided on other issues. With oil and gas prices surging, some energy-producing countries such as Russia and Saudi Arabia have not boosted output enough to satisfy countries that are largely consumers of energy and worry about energy shortages and inflation.</p>\n<p>Biden's top advisers have voiced concerns about energy suppliers not boosting production enough to meet surging demand.</p>\n<p>Rocketing natural gas prices, with the European benchmark up almost 600% this year, have been fuelled by low inventories and surging demand as economies recover from the COVID-19 crisis.</p>\n<p>Biden's national security adviser Jake Sullivan raised similar issues</p>\n<p>during a visit to Brussels this month, singling out Russia for its \"history of using energy as a tool of coercion, as a political weapon.\"</p>\n<p>Russia, a major natural gas supplier to Europe, and its energy giant Gazprom are being urged to do more to ease prices in the spot market.</p>\n<p>\"It's a delicate time in the global economy, and what's important is that global energy supplies keep up with global energy demand,\" the senior administration official said.</p>\n<p>\"There are major energy producers that have spare capacity, and we're encouraging them to use to ensure a stronger, more sustainable recovery across the world,\" the official said, without naming any specific countries.</p>\n<p>The official said G20 leaders would not specifically target the Organization of the Petroleum Exporting Countries (OPEC), which includes Saudi Arabia, or set any targets for energy production.</p>\n<p>Russian President Vladimir Putin will not attend the summit in person, but is expected to participate virtually.</p>\n<p>Comments from Russian Deputy Prime Minister Alexander Novak earlier this month sparked fresh tensions over the Nord Stream 2 undersea gas pipeline, which Washington has long opposed and which is now awaiting clearance from a German regulator.</p>\n<p>Novak said clearing the pipeline could help ease shortfalls, sparking concerns that Russia has failed to boost its production of gas - now delivered via land-based pipelines - precisely to put pressure on Europe to approve Nord Stream 2.</p>\n<p>During their talks on the economy, G20 leaders will also back an agreement reached by more than 130 countries on a global minimum corporate tax of 15% that will reshape the world economy and could result in some $60 billion in additional tax revenues per year for the United States alone, the official said.</p>\n<p>\"The deal is a testament to American diplomacy and leadership,\" the official said, noting that Biden and Treasury Secretary Janet Yellen had worked hard to secure the agreement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DDG":"ProShares做空石油与天然气ETF","DGAZ":"三倍做空天然气ETN(VelocityShares)","UGAZ":"三倍做多天然气ETN(VelocityShares)","USO":"美国原油ETF","UCO":"二倍做多彭博原油ETF","UNG":"美国天然气基金","DUG":"二倍做空石油与天然气ETF(ProShares)","SCO":"二倍做空彭博原油指数ETF","DWT":"三倍做空原油ETN"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179223698","content_text":"ROME, Oct 30 (Reuters) - U.S. President Joe Biden on Saturday will urge major G20 energy producers with spare capacity to boost production to ensure a stronger global economic recovery, a senior administration official said ahead of a summit bringing together leaders of the world's largest economies.\nBiden and other Group of 20 leaders are slated to discuss efforts to end the COVID-19 pandemic and agree on a new task force to improve coordination and planning to prevent the next one. They also expect to endorse an agreement backed by more than 130 countries to establish a new global minimum tax.\nBut members are divided on other issues. With oil and gas prices surging, some energy-producing countries such as Russia and Saudi Arabia have not boosted output enough to satisfy countries that are largely consumers of energy and worry about energy shortages and inflation.\nBiden's top advisers have voiced concerns about energy suppliers not boosting production enough to meet surging demand.\nRocketing natural gas prices, with the European benchmark up almost 600% this year, have been fuelled by low inventories and surging demand as economies recover from the COVID-19 crisis.\nBiden's national security adviser Jake Sullivan raised similar issues\nduring a visit to Brussels this month, singling out Russia for its \"history of using energy as a tool of coercion, as a political weapon.\"\nRussia, a major natural gas supplier to Europe, and its energy giant Gazprom are being urged to do more to ease prices in the spot market.\n\"It's a delicate time in the global economy, and what's important is that global energy supplies keep up with global energy demand,\" the senior administration official said.\n\"There are major energy producers that have spare capacity, and we're encouraging them to use to ensure a stronger, more sustainable recovery across the world,\" the official said, without naming any specific countries.\nThe official said G20 leaders would not specifically target the Organization of the Petroleum Exporting Countries (OPEC), which includes Saudi Arabia, or set any targets for energy production.\nRussian President Vladimir Putin will not attend the summit in person, but is expected to participate virtually.\nComments from Russian Deputy Prime Minister Alexander Novak earlier this month sparked fresh tensions over the Nord Stream 2 undersea gas pipeline, which Washington has long opposed and which is now awaiting clearance from a German regulator.\nNovak said clearing the pipeline could help ease shortfalls, sparking concerns that Russia has failed to boost its production of gas - now delivered via land-based pipelines - precisely to put pressure on Europe to approve Nord Stream 2.\nDuring their talks on the economy, G20 leaders will also back an agreement reached by more than 130 countries on a global minimum corporate tax of 15% that will reshape the world economy and could result in some $60 billion in additional tax revenues per year for the United States alone, the official said.\n\"The deal is a testament to American diplomacy and leadership,\" the official said, noting that Biden and Treasury Secretary Janet Yellen had worked hard to secure the agreement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887318039,"gmtCreate":1631975068921,"gmtModify":1632805011679,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/887318039","repostId":"2168957763","repostType":4,"repost":{"id":"2168957763","kind":"news","pubTimestamp":1631950800,"share":"https://www.laohu8.com/m/news/2168957763?lang=&edition=full","pubTime":"2021-09-18 15:40","market":"us","language":"en","title":"FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2168957763","media":"StreetInsider","summary":"Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization ti","content":"<ul>\n <li><i>Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against SARS-CoV-2 and all currently tested variants </i></li>\n <li><i>Reactogenicity profile within seven days of the booster dose was typically mild to moderate, with frequency of reactions similar to or lower than after the primary vaccination series</i></li>\n <li><i>Real-world data presented by Israel Ministry of Health show additional protection after receiving a</i> <i>booster translated to vaccine effectiveness comparable to levels seen early in the country’s vaccine</i> <i>rollout</i></li>\n <li><i>FDA expected to make its decision in the coming days </i></li>\n</ul>\n<p><b>NEW YORK AND MAINZ, GERMANY, September 17, 2021</b>—Pfizer Inc. (NYSE: PFE) and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the FDA grant Emergency Use Authorization (EUA) for a booster dose of COMIRNATY® (COVID-19 Vaccine, mRNA) in individuals 65 years of age and older and individuals at high risk of severe COVID-19. The committee recommended that the additional dose be administered at least six months after the two-dose series. The panel also agreed that healthcare workers and others at high risk for occupational exposure should be included in this EUA.</p>\n<p>VRBPAC is made up of independent experts who advise the FDA on scientific and regulatory matters, including the evaluation of vaccine safety and efficacy.</p>\n<p>At this time, VRBPAC did not vote in favor of approval of a booster dose for the full population for which Pfizer and BioNTech submitted their supplemental Biologics License Application, which was individuals 16 and older. The same data have recently been submitted to the European Medicines Agency (EMA) and will be filed with other regulatory authorities in the coming weeks. The companies remain vigilant and continue to generate relevant COMIRNATY booster dose data for evaluation for future licensure in further groups as well as to address emerging variants of concern.</p>\n<p>The FDA is expected to make its decision in the coming days. This decision could allow COMIRNATY to be the first COVID-19 vaccine with a booster authorized in the U.S.</p>\n<p>“Today the VRBPAC reviewed data from our clinical program showing a favorable safety profile and strong immune responses against SARS-CoV-2 after a booster dose of our vaccine. These data, and the larger body of scientific evidence presented at the meeting, underscore our belief that boosters can be a critical tool in the ongoing effort to control the spread of this virus,” said <b>Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research &amp; Development, Pfizer</b>. “We thank the committee for their thoughtful review of the data and will work with the FDA following today’s meeting to address the committee’s questions, as we continue to believe in the benefits of a booster dose for a broader population.”</p>\n<p>“We are committed to support the ongoing efforts to reduce infections and COVID-19 cases. The data we submitted to the FDA, EMA and other regulatory authorities underline that a booster induces a strong immune response against all tested variants of concern and may contribute to address a public health need,” said <b>Özlem Türeci, M.D., Co-founder and Chief Medical Officer of BioNTech.</b></p>\n<p>VRBPAC based its recommendation on the totality of scientific evidence shared by the companies, including data from their clinical program evaluating the safety, tolerability and immunogenicity of a booster dose of COMIRNATY. A booster dose of the vaccine elicited significantly higher neutralizing antibody titers against the initial SARS-CoV-2 virus (wild type), as well as the Beta and Delta variants, when compared with the levels observed after the two-dose primary series. The reactogenicity profile within seven days after the booster dose was typically mild to moderate, and the frequency of reactions was similar to or lower than after dose two. The adverse event profile was generally consistent with other clinical safety data for COMIRNATY.</p>\n<p>Real-world surveillance data also were presented to the VRBPAC by the Israel Ministry of Health, providing further support for the public health impact of boosters. The data presented from Israel included an analysis published this week in <i>The New England Journal of Medicine</i>. The analysis comprised approximately 1.1 million individuals ages 60 years and older who were eligible for a booster dose of the vaccine between July 30 through August 31, 2021. No new safety signals were observed, and reported adverse events were lower than those observed after dose two. The analysis showed that a booster dose restored very high levels of protection against COVID-19 infections and severe disease in this period when Delta was the dominant strain. Individuals who received the booster dose were less likely by a factor of 11.3 (95% CI: 10.4, 12.3) to develop a confirmed infection and less likely by a factor of 19.5 (95% CI: 12.9, 29.5) to develop severe illness compared to those who were previously fully vaccinated but did not receive a booster dose. The additional protection after receiving a booster translated to vaccine effectiveness comparable to levels seen early in the country’s vaccine rollout (an estimated 95%), when the Alpha variant was predominant.</p>\n<p>Under the EUA of the Pfizer-BioNTech vaccine in the U.S., a third dose was <u>previously authorized</u> for individuals at least 12 years of age who have undergone solid organ transplant, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. This authorization of a third dose for immunocompromised individuals is separate and distinct from the booster dose reviewed by VRBPAC today. The third dose for immunocompromised individuals is meant to address the fact that these individuals sometimes do not build enough protection after two doses of the vaccine. In contrast, the booster dose recommended today by VRBPAC for EUA refers to an additional dose of the vaccine that is given to those who have built enough protection after the primary two-dose vaccination series, but may have decreased protection over time due to waning of immunity.</p>\n<p>COMIRNATY, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the United States, the European Union, the United Kingdom, Canada and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries. Submissions to pursue regulatory approvals in those countries where emergency use authorizations or equivalent were initially granted are planned.</p>\n<p><b>U.S. Indication &amp; Authorized Use</b>COMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.</p>\n<ul>\n <li>It is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older</li>\n <li>It is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:</li>\n</ul>\n<p>The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to:</p>\n<ul>\n <li>prevent COVID-19 in individuals 12 years of age and older, and</li>\n <li>provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise</li>\n</ul>\n<p>The FDA-approved COMIRNATY® (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. An individual may be offered either COMIRNATY® (COVID-19 Vaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.</p>\n<p><b>EUA Statement</b>This emergency use of the product has not been approved or licensed by FDA, but has been authorized by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 12 years of age and older; and the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&amp;C Act unless the declaration is terminated or authorization revoked sooner.</p>\n<p><b>Important Safety Information</b>Individuals should <b>not</b> get the Pfizer-BioNTech COVID-19 Vaccine if they:</p>\n<ul>\n <li>had a severe allergic reaction after a previous dose of this vaccine</li>\n <li>had a severe allergic reaction to any ingredient of this vaccine</li>\n</ul>\n<p>Individuals should tell the vaccination provider about all of their medical conditions, including if they:</p>\n<ul>\n <li>have any allergies</li>\n <li>have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)</li>\n <li>have a fever</li>\n <li>have a bleeding disorder or are on a blood thinner</li>\n <li>are immunocompromised or are on a medicine that affects the immune system</li>\n <li>are pregnant, plan to become pregnant, or are breastfeeding</li>\n <li>have received another COVID-19 vaccine</li>\n <li>have ever fainted in association with an injection</li>\n</ul>\n<p>The vaccine may not protect everyone.</p>\n<p>Side effects reported with the vaccine include:</p>\n<ul>\n <li>There is a remote chance that the vaccine could cause a severe allergic reaction</li>\n <li>Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received the vaccine. In most of these people, symptoms began within a few days following receipt of the second dose of the vaccine. The chance of having this occur is very low. Individuals should seek medical attention right away if they have any of the following symptoms after receiving the vaccine:</li>\n <li>Side effects that have been reported with the vaccine include:</li>\n <li>These may not be all the possible side effects of the vaccine. Serious and unexpected side effects may occur. The vaccine is still being studied in clinical trials. Call the vaccination provider or healthcare provider about bothersome side effects or side effects that do not go away</li>\n</ul>\n<p>There is no information on the use of the vaccine with other vaccines.</p>\n<p>Patients should always ask their healthcare providers for medical advice about adverse events. Individuals are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit <u>http://www.vaers.hhs.gov</u> or call 1-800-822-7967. In addition, side effects can be reported to Pfizer Inc. at <u>www.pfizersafetyreporting.com</u> or by calling 1-800-438-1985.</p>\n<p>Please <u>click here</u> for full Prescribing Information (16+ years of age). Please <u>click here</u> for Fact Sheet for Vaccination Providers (12+ years of age).</p>\n<p><b>About Pfizer: Breakthroughs That Change Patients’ Lives</b>At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at <u>www.Pfizer.com</u>. In addition, to learn more, please visit us on <u>www.Pfizer.com</u> and follow us on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> at <u>@Pfizer</u> and <u>@Pfizer News</u>, <u>LinkedIn</u>, <u>YouTube</u> and like us on <a href=\"https://laohu8.com/S/FB\">Facebook</a> at <u>Facebook.com/Pfizer</u>.</p>\n<p><b>Pfizer Disclosure Notice</b>The information contained in this release is as of September 17, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.</p>\n<p>This release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162 mRNA vaccine program and COMIRNATY (COVID-19 Vaccine, mRNA) (BNT162b2) (including a potential booster (third) dose and a supplemental Biologics License Application (sBLA) for a potential booster (third) dose of BNT162b2 in individuals 16 years of age and older in the U.S., qualitative assessments of available data, potential benefits, expectations for clinical trials, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply) involving substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preclinical and clinical data (including the Phase 3 data), including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data; whether and when our Phase 3 clinical trial will demonstrate protection from infection or disease following a booster (third) dose, which is the subject of ongoing study; the ability to produce comparable clinical or other results, including the rate of vaccine effectiveness and safety and tolerability profile observed to date, in additional analyses of the Phase 3 trial and additional studies or in larger, more diverse populations following commercialization; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the risk that more widespread use of the vaccine will lead to new information about efficacy, safety, or other developments, including the risk of additional adverse reactions, some of which may be serious; the risk that preclinical and clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when additional data from the BNT162 mRNA vaccine program will be published in scientific journal publications and, if so, when and with what modifications and interpretations; whether regulatory authorities will be satisfied with the design of and results from these and any future preclinical and clinical studies; whether and when applications for a potential booster (third) dose will be filed in any other jurisdictions and whether and when other biologics license and/or emergency use authorization applications or amendments to any such applications may be filed in particular jurisdictions for BNT162b2 or any other potential vaccines that may arise from the BNT162 program, and if obtained, whether or when such emergency use authorization or licenses will expire or terminate; whether and when any applications that may be pending or filed for BNT162b2 (including the sBLA for a potential booster (third) dose in the U.S., applications that may be pending or filed for a potential booster (third) dose in other jurisdictions or any requested amendments to the emergency use or conditional marketing authorizations) or other vaccines that may result from the BNT162 program may be approved by particular regulatory authorities, which will depend on myriad factors, including making a determination as to whether the vaccine’s benefits outweigh its known risks and determination of the vaccine’s efficacy and, if approved, whether it will be commercially successful; decisions by regulatory authorities impacting labeling or marketing, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of a vaccine, including development of products or therapies by other companies; disruptions in the relationships between us and our collaboration partners, clinical trial sites or third-party suppliers; the risk that demand for any products may be reduced or no longer exist; risks related to the availability of raw materials to manufacture a vaccine; challenges related to our vaccine’s ultra-low temperature formulation, two-dose schedule and attendant storage, distribution and administration requirements, including risks related to storage and handling after delivery by Pfizer; the risk that we may not be able to successfully develop other vaccine formulations, booster doses or new variant-specific vaccines; the risk that we may not be able to create or scale up manufacturing capacity on a timely basis or maintain access to logistics or supply channels commensurate with global demand for our vaccine, which would negatively impact our ability to supply the estimated numbers of doses of our vaccine within the projected time periods as previously indicated; whether and when additional supply agreements will be reached; uncertainties regarding the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; challenges related to public vaccine confidence or awareness; uncertainties regarding the impact of COVID-19 on Pfizer’s business, operations and financial results; and competitive developments.</p>\n<p>A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at <u>www.sec.gov</u> and <u>www.pfizer.com</u>.</p>\n<p><b>About BioNTech</b>Biopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit <u>www.BioNTech.de</u>.</p>\n<p><b>BioNTech Forward-looking Statements</b>This press release contains “forward-looking statements” of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech’s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer including the program to develop a COVID-19 vaccine and COMIRNATY (COVID-19 Vaccine, mRNA) (BNT162b2) (including a potential booster (third) dose of BNT162b2 in individuals 16 years of age and older in the U.S., a definite submission of a supplemental BLA for a potential booster dose of a variation of BNT162b2 having a modified mRNA sequence in the U.S., a BLA to support potential full FDA approval of BNT162b2 in individuals 12 through 15 years, whether and when applications for a potential booster (third) dose will be filed in any other jurisdictions, qualitative assessments of available data, potential benefits, expectations for clinical trials, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply); our expectations regarding the potential characteristics of BNT162b2 in our clinical trials and/or in commercial use based on data observations to date; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the expected time point for additional readouts on efficacy data of BNT162b2 in our clinical trials; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval or Emergency Use Authorization; our contemplated shipping and storage plan, including our estimated product shelf life at various temperatures; and the ability of BioNTech to supply the quantities of BNT162 to support clinical development and market demand, including our production estimates for 2021. Any forward-looking statements in this press release are based on BioNTech current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the ability to meet the pre-defined endpoints in clinical trials; competition to create a vaccine for COVID-19; the ability to produce comparable clinical or other results, including our stated rate of vaccine effectiveness and safety and tolerability profile observed to date, in the remainder of the trial or in larger, more diverse populations upon commercialization; the ability to effectively scale our productions capabilities; and other potential difficulties.</p>\n<p>For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report as Form 20-F for the Year Ended December 31, 2020, filed with the SEC on March 30, 2021, which is available on the SEC’s website at <u>www.sec.gov</u>. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-18 15:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18955632><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against SARS-CoV-2 and all currently tested variants \nReactogenicity profile within seven days ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18955632\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18955632","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168957763","content_text":"Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against SARS-CoV-2 and all currently tested variants \nReactogenicity profile within seven days of the booster dose was typically mild to moderate, with frequency of reactions similar to or lower than after the primary vaccination series\nReal-world data presented by Israel Ministry of Health show additional protection after receiving a booster translated to vaccine effectiveness comparable to levels seen early in the country’s vaccine rollout\nFDA expected to make its decision in the coming days \n\nNEW YORK AND MAINZ, GERMANY, September 17, 2021—Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted unanimously to recommend the FDA grant Emergency Use Authorization (EUA) for a booster dose of COMIRNATY® (COVID-19 Vaccine, mRNA) in individuals 65 years of age and older and individuals at high risk of severe COVID-19. The committee recommended that the additional dose be administered at least six months after the two-dose series. The panel also agreed that healthcare workers and others at high risk for occupational exposure should be included in this EUA.\nVRBPAC is made up of independent experts who advise the FDA on scientific and regulatory matters, including the evaluation of vaccine safety and efficacy.\nAt this time, VRBPAC did not vote in favor of approval of a booster dose for the full population for which Pfizer and BioNTech submitted their supplemental Biologics License Application, which was individuals 16 and older. The same data have recently been submitted to the European Medicines Agency (EMA) and will be filed with other regulatory authorities in the coming weeks. The companies remain vigilant and continue to generate relevant COMIRNATY booster dose data for evaluation for future licensure in further groups as well as to address emerging variants of concern.\nThe FDA is expected to make its decision in the coming days. This decision could allow COMIRNATY to be the first COVID-19 vaccine with a booster authorized in the U.S.\n“Today the VRBPAC reviewed data from our clinical program showing a favorable safety profile and strong immune responses against SARS-CoV-2 after a booster dose of our vaccine. These data, and the larger body of scientific evidence presented at the meeting, underscore our belief that boosters can be a critical tool in the ongoing effort to control the spread of this virus,” said Kathrin U. Jansen, Ph.D., Senior Vice President and Head of Vaccine Research & Development, Pfizer. “We thank the committee for their thoughtful review of the data and will work with the FDA following today’s meeting to address the committee’s questions, as we continue to believe in the benefits of a booster dose for a broader population.”\n“We are committed to support the ongoing efforts to reduce infections and COVID-19 cases. The data we submitted to the FDA, EMA and other regulatory authorities underline that a booster induces a strong immune response against all tested variants of concern and may contribute to address a public health need,” said Özlem Türeci, M.D., Co-founder and Chief Medical Officer of BioNTech.\nVRBPAC based its recommendation on the totality of scientific evidence shared by the companies, including data from their clinical program evaluating the safety, tolerability and immunogenicity of a booster dose of COMIRNATY. A booster dose of the vaccine elicited significantly higher neutralizing antibody titers against the initial SARS-CoV-2 virus (wild type), as well as the Beta and Delta variants, when compared with the levels observed after the two-dose primary series. The reactogenicity profile within seven days after the booster dose was typically mild to moderate, and the frequency of reactions was similar to or lower than after dose two. The adverse event profile was generally consistent with other clinical safety data for COMIRNATY.\nReal-world surveillance data also were presented to the VRBPAC by the Israel Ministry of Health, providing further support for the public health impact of boosters. The data presented from Israel included an analysis published this week in The New England Journal of Medicine. The analysis comprised approximately 1.1 million individuals ages 60 years and older who were eligible for a booster dose of the vaccine between July 30 through August 31, 2021. No new safety signals were observed, and reported adverse events were lower than those observed after dose two. The analysis showed that a booster dose restored very high levels of protection against COVID-19 infections and severe disease in this period when Delta was the dominant strain. Individuals who received the booster dose were less likely by a factor of 11.3 (95% CI: 10.4, 12.3) to develop a confirmed infection and less likely by a factor of 19.5 (95% CI: 12.9, 29.5) to develop severe illness compared to those who were previously fully vaccinated but did not receive a booster dose. The additional protection after receiving a booster translated to vaccine effectiveness comparable to levels seen early in the country’s vaccine rollout (an estimated 95%), when the Alpha variant was predominant.\nUnder the EUA of the Pfizer-BioNTech vaccine in the U.S., a third dose was previously authorized for individuals at least 12 years of age who have undergone solid organ transplant, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. This authorization of a third dose for immunocompromised individuals is separate and distinct from the booster dose reviewed by VRBPAC today. The third dose for immunocompromised individuals is meant to address the fact that these individuals sometimes do not build enough protection after two doses of the vaccine. In contrast, the booster dose recommended today by VRBPAC for EUA refers to an additional dose of the vaccine that is given to those who have built enough protection after the primary two-dose vaccination series, but may have decreased protection over time due to waning of immunity.\nCOMIRNATY, which is based on BioNTech’s proprietary mRNA technology, was developed by both BioNTech and Pfizer. BioNTech is the Marketing Authorization Holder in the United States, the European Union, the United Kingdom, Canada and the holder of emergency use authorizations or equivalents in the United States (jointly with Pfizer) and other countries. Submissions to pursue regulatory approvals in those countries where emergency use authorizations or equivalent were initially granted are planned.\nU.S. Indication & Authorized UseCOMIRNATY® (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech.\n\nIt is approved as a 2-dose series for prevention of COVID-19 in individuals 16 years of age and older\nIt is also authorized under Emergency Use Authorization (EUA) to be administered for emergency use to:\n\nThe Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to:\n\nprevent COVID-19 in individuals 12 years of age and older, and\nprovide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise\n\nThe FDA-approved COMIRNATY® (COVID-19 Vaccine, mRNA) and the EUA-authorized Pfizer-BioNTech COVID-19 Vaccine have the same formulation and can be used interchangeably to provide the COVID-19 vaccination series. An individual may be offered either COMIRNATY® (COVID-19 Vaccine, mRNA) or the Pfizer-BioNTech COVID-19 Vaccine to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.\nEUA StatementThis emergency use of the product has not been approved or licensed by FDA, but has been authorized by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 12 years of age and older; and the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.\nImportant Safety InformationIndividuals should not get the Pfizer-BioNTech COVID-19 Vaccine if they:\n\nhad a severe allergic reaction after a previous dose of this vaccine\nhad a severe allergic reaction to any ingredient of this vaccine\n\nIndividuals should tell the vaccination provider about all of their medical conditions, including if they:\n\nhave any allergies\nhave had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)\nhave a fever\nhave a bleeding disorder or are on a blood thinner\nare immunocompromised or are on a medicine that affects the immune system\nare pregnant, plan to become pregnant, or are breastfeeding\nhave received another COVID-19 vaccine\nhave ever fainted in association with an injection\n\nThe vaccine may not protect everyone.\nSide effects reported with the vaccine include:\n\nThere is a remote chance that the vaccine could cause a severe allergic reaction\nMyocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred in some people who have received the vaccine. In most of these people, symptoms began within a few days following receipt of the second dose of the vaccine. The chance of having this occur is very low. Individuals should seek medical attention right away if they have any of the following symptoms after receiving the vaccine:\nSide effects that have been reported with the vaccine include:\nThese may not be all the possible side effects of the vaccine. Serious and unexpected side effects may occur. The vaccine is still being studied in clinical trials. Call the vaccination provider or healthcare provider about bothersome side effects or side effects that do not go away\n\nThere is no information on the use of the vaccine with other vaccines.\nPatients should always ask their healthcare providers for medical advice about adverse events. Individuals are encouraged to report negative side effects of vaccines to the US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC). Visit http://www.vaers.hhs.gov or call 1-800-822-7967. In addition, side effects can be reported to Pfizer Inc. at www.pfizersafetyreporting.com or by calling 1-800-438-1985.\nPlease click here for full Prescribing Information (16+ years of age). Please click here for Fact Sheet for Vaccination Providers (12+ years of age).\nAbout Pfizer: Breakthroughs That Change Patients’ LivesAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.\nPfizer Disclosure NoticeThe information contained in this release is as of September 17, 2021. Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.\nThis release contains forward-looking information about Pfizer’s efforts to combat COVID-19, the collaboration between BioNTech and Pfizer to develop a COVID-19 vaccine, the BNT162 mRNA vaccine program and COMIRNATY (COVID-19 Vaccine, mRNA) (BNT162b2) (including a potential booster (third) dose and a supplemental Biologics License Application (sBLA) for a potential booster (third) dose of BNT162b2 in individuals 16 years of age and older in the U.S., qualitative assessments of available data, potential benefits, expectations for clinical trials, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply) involving substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as risks associated with preclinical and clinical data (including the Phase 3 data), including the possibility of unfavorable new preclinical, clinical or safety data and further analyses of existing preclinical, clinical or safety data; whether and when our Phase 3 clinical trial will demonstrate protection from infection or disease following a booster (third) dose, which is the subject of ongoing study; the ability to produce comparable clinical or other results, including the rate of vaccine effectiveness and safety and tolerability profile observed to date, in additional analyses of the Phase 3 trial and additional studies or in larger, more diverse populations following commercialization; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the risk that more widespread use of the vaccine will lead to new information about efficacy, safety, or other developments, including the risk of additional adverse reactions, some of which may be serious; the risk that preclinical and clinical trial data are subject to differing interpretations and assessments, including during the peer review/publication process, in the scientific community generally, and by regulatory authorities; whether and when additional data from the BNT162 mRNA vaccine program will be published in scientific journal publications and, if so, when and with what modifications and interpretations; whether regulatory authorities will be satisfied with the design of and results from these and any future preclinical and clinical studies; whether and when applications for a potential booster (third) dose will be filed in any other jurisdictions and whether and when other biologics license and/or emergency use authorization applications or amendments to any such applications may be filed in particular jurisdictions for BNT162b2 or any other potential vaccines that may arise from the BNT162 program, and if obtained, whether or when such emergency use authorization or licenses will expire or terminate; whether and when any applications that may be pending or filed for BNT162b2 (including the sBLA for a potential booster (third) dose in the U.S., applications that may be pending or filed for a potential booster (third) dose in other jurisdictions or any requested amendments to the emergency use or conditional marketing authorizations) or other vaccines that may result from the BNT162 program may be approved by particular regulatory authorities, which will depend on myriad factors, including making a determination as to whether the vaccine’s benefits outweigh its known risks and determination of the vaccine’s efficacy and, if approved, whether it will be commercially successful; decisions by regulatory authorities impacting labeling or marketing, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of a vaccine, including development of products or therapies by other companies; disruptions in the relationships between us and our collaboration partners, clinical trial sites or third-party suppliers; the risk that demand for any products may be reduced or no longer exist; risks related to the availability of raw materials to manufacture a vaccine; challenges related to our vaccine’s ultra-low temperature formulation, two-dose schedule and attendant storage, distribution and administration requirements, including risks related to storage and handling after delivery by Pfizer; the risk that we may not be able to successfully develop other vaccine formulations, booster doses or new variant-specific vaccines; the risk that we may not be able to create or scale up manufacturing capacity on a timely basis or maintain access to logistics or supply channels commensurate with global demand for our vaccine, which would negatively impact our ability to supply the estimated numbers of doses of our vaccine within the projected time periods as previously indicated; whether and when additional supply agreements will be reached; uncertainties regarding the ability to obtain recommendations from vaccine advisory or technical committees and other public health authorities and uncertainties regarding the commercial impact of any such recommendations; challenges related to public vaccine confidence or awareness; uncertainties regarding the impact of COVID-19 on Pfizer’s business, operations and financial results; and competitive developments.\nA further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results”, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com.\nAbout BioNTechBiopharmaceutical New Technologies is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases. The Company exploits a wide array of computational discovery and therapeutic drug platforms for the rapid development of novel biopharmaceuticals. Its broad portfolio of oncology product candidates includes individualized and off-the-shelf mRNA-based therapies, innovative chimeric antigen receptor T cells, bi-specific checkpoint immuno-modulators, targeted cancer antibodies and small molecules. Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities, BioNTech and its collaborators are developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global pharmaceutical collaborators, including Genmab, Sanofi, Bayer Animal Health, Genentech, a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit www.BioNTech.de.\nBioNTech Forward-looking StatementsThis press release contains “forward-looking statements” of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may include, but may not be limited to, statements concerning: BioNTech’s efforts to combat COVID-19; the collaboration between BioNTech and Pfizer including the program to develop a COVID-19 vaccine and COMIRNATY (COVID-19 Vaccine, mRNA) (BNT162b2) (including a potential booster (third) dose of BNT162b2 in individuals 16 years of age and older in the U.S., a definite submission of a supplemental BLA for a potential booster dose of a variation of BNT162b2 having a modified mRNA sequence in the U.S., a BLA to support potential full FDA approval of BNT162b2 in individuals 12 through 15 years, whether and when applications for a potential booster (third) dose will be filed in any other jurisdictions, qualitative assessments of available data, potential benefits, expectations for clinical trials, the anticipated timing of regulatory submissions, regulatory approvals or authorizations and anticipated manufacturing, distribution and supply); our expectations regarding the potential characteristics of BNT162b2 in our clinical trials and/or in commercial use based on data observations to date; the ability of BNT162b2 to prevent COVID-19 caused by emerging virus variants; the expected time point for additional readouts on efficacy data of BNT162b2 in our clinical trials; the nature of the clinical data, which is subject to ongoing peer review, regulatory review and market interpretation; the timing for submission of data for, or receipt of, any marketing approval or Emergency Use Authorization; our contemplated shipping and storage plan, including our estimated product shelf life at various temperatures; and the ability of BioNTech to supply the quantities of BNT162 to support clinical development and market demand, including our production estimates for 2021. Any forward-looking statements in this press release are based on BioNTech current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the ability to meet the pre-defined endpoints in clinical trials; competition to create a vaccine for COVID-19; the ability to produce comparable clinical or other results, including our stated rate of vaccine effectiveness and safety and tolerability profile observed to date, in the remainder of the trial or in larger, more diverse populations upon commercialization; the ability to effectively scale our productions capabilities; and other potential difficulties.\nFor a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report as Form 20-F for the Year Ended December 31, 2020, filed with the SEC on March 30, 2021, which is available on the SEC’s website at www.sec.gov. All information in this press release is as of the date of the release, and BioNTech undertakes no duty to update this information unless required by law.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891931298,"gmtCreate":1628315148514,"gmtModify":1633751699998,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/891931298","repostId":"1159359820","repostType":4,"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146849254,"gmtCreate":1626069753878,"gmtModify":1633930434720,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/146849254","repostId":"1114863871","repostType":4,"isVote":1,"tweetType":1,"viewCount":145,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":605457314,"gmtCreate":1639230483343,"gmtModify":1639230483618,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605457314","repostId":"2190205546","repostType":4,"isVote":1,"tweetType":1,"viewCount":1325,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605455750,"gmtCreate":1639230069371,"gmtModify":1639230069609,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/605455750","repostId":"2190675480","repostType":4,"repost":{"id":"2190675480","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1639187514,"share":"https://www.laohu8.com/m/news/2190675480?lang=&edition=full","pubTime":"2021-12-11 09:51","market":"us","language":"en","title":"3M hit with $22.5 million verdict in latest U.S. military earplug trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2190675480","media":"Reuters","summary":"Dec 10  - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by $3M$ Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.Finley, who used th","content":"<p>Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by <a href=\"https://laohu8.com/S/MMM\">3M</a> Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.</p>\n<p>Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.</p>\n<p>Finley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.</p>\n<p>The trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.</p>\n<p>\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.</p>\n<p>3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.</p>\n<p>Aearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.</p>\n<p>For the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.</p>\n<p>(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)</p>\n<p>((Nate.Raymond@thomsonreuters.com and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3M hit with $22.5 million verdict in latest U.S. military earplug trial</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3M hit with $22.5 million verdict in latest U.S. military earplug trial\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-11 09:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by <a href=\"https://laohu8.com/S/MMM\">3M</a> Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.</p>\n<p>Jurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.</p>\n<p>Finley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.</p>\n<p>The trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.</p>\n<p>\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.</p>\n<p>3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.</p>\n<p>Aearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.</p>\n<p>For the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.</p>\n<p>(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)</p>\n<p>((Nate.Raymond@thomsonreuters.com and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","MMM":"3M","BK4512":"苹果概念","BK4206":"工业集团企业"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190675480","content_text":"Dec 10 (Reuters) - A federal jury on Friday awarded $22.5 million to a U.S. Army veteran who alleged that combat earplugs sold by 3M Co caused him to suffer hearing loss and tinnitus, the biggest verdict yet in massive litigation over the product.\nJurors in Pensacola, Florida, sided with former U.S. Army soldier Theodore Finley in the latest trial to result from more than 272,000 lawsuits by servicemembers and veterans who say defective earplugs made by 3M caused their hearing damage.\nFinley, who used the earplugs while serving in the Army from 2006 to 2014, was awarded $7.5 million in compensatory damages and $15 million in punitive damages. The verdict surpassed the $13 million jurors awarded a U.S. Army sergeant last month.\nThe trial was the eighth so far to reach a verdict, with plaintiffs in four other cases winning more than $28 million combined. Juries sided 3M in three others, and two more trials are underway, with more to come.\n\"We will ensure that 3M is held fully accountable for putting profits over the safety of those who served our nation,\" the lead lawyers for the plaintiffs - Bryan Aylstock, Shelley Hutson and Christopher Seeger - said in a joint statement.\n3M did not respond to a request for comment. It has contended the Combat Arms Earplugs Version 2 were effective and safe to use.\nAearo Technologies LLC, which 3M bought in 2008, developed the product. Plaintiffs allege the company hid design flaws, fudged test results and failed to provide instruction in the proper use of the earplugs.\nFor the earplugs to work properly, the flexible cups on the side protruding from the ear sometimes had to be folded back. If not, the plugs would slowly loosen and noise would seep in. Veterans contend 3M failed to convey the need to fold the plugs.\n(Reporting by Nate Raymond in Boston Editing by Sonya Hepinstall)\n((Nate.Raymond@thomsonreuters.com and Twitter @nateraymond; 347-243-6917; Reuters Messaging: nate.raymond.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":1103,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":895043063,"gmtCreate":1628696745952,"gmtModify":1633745022011,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/895043063","repostId":"2158528016","repostType":4,"repost":{"id":"2158528016","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1628694066,"share":"https://www.laohu8.com/m/news/2158528016?lang=&edition=full","pubTime":"2021-08-11 23:01","market":"us","language":"en","title":"Why AppHarvest Shares Are Getting Slammed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2158528016","media":"Benzinga","summary":"AppHarvest Inc (NASDAQ: APPH) is trading significantly lower Wednesday after the company announced worse-than-expected second-quarter financial results and cut guidance.","content":"<p><b>AppHarvest Inc</b> (NASDAQ:APPH) is trading significantly lower Wednesday after the company announced worse-than-expected second-quarter financial results and cut guidance.</p>\n<p>AppHarvest reported a quarterly earnings loss of 32 cents per share, which came in below the estimate for a loss of 19 cents per share. The company reported quarterly revenue of $3.1 million, which came in below the estimate of $5.87 million.</p>\n<p>AppHarvest lowered its full-year 2021 revenue guidance from a range of $20 million to $25 million to a range of $7 million to $9 million.</p>\n<p>“We believe our innovative, sustainable approach, which captures free rainwater and sunlight through large glass roofs in Appalachia and leverages world-class technology at scale while maintaining the highest ESG principles, positions our company to be a global leader in this industry,”&nbsp;said&nbsp;<b>Jonathan Webb</b>,&nbsp;founder and CEO of AppHarvest.</p>\n<p>AppHarvest is an agriculture technology company&nbsp;engaged in developing and operating controlled environment indoor farms.</p>\n<p><b>Price Action:</b> AppHarvest is making a new 52-week low in trading today.</p>\n<p>At last check Wednesday, the stock was down 38.30% at $7.39.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why AppHarvest Shares Are Getting Slammed Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy AppHarvest Shares Are Getting Slammed Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-11 23:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>AppHarvest Inc</b> (NASDAQ:APPH) is trading significantly lower Wednesday after the company announced worse-than-expected second-quarter financial results and cut guidance.</p>\n<p>AppHarvest reported a quarterly earnings loss of 32 cents per share, which came in below the estimate for a loss of 19 cents per share. The company reported quarterly revenue of $3.1 million, which came in below the estimate of $5.87 million.</p>\n<p>AppHarvest lowered its full-year 2021 revenue guidance from a range of $20 million to $25 million to a range of $7 million to $9 million.</p>\n<p>“We believe our innovative, sustainable approach, which captures free rainwater and sunlight through large glass roofs in Appalachia and leverages world-class technology at scale while maintaining the highest ESG principles, positions our company to be a global leader in this industry,”&nbsp;said&nbsp;<b>Jonathan Webb</b>,&nbsp;founder and CEO of AppHarvest.</p>\n<p>AppHarvest is an agriculture technology company&nbsp;engaged in developing and operating controlled environment indoor farms.</p>\n<p><b>Price Action:</b> AppHarvest is making a new 52-week low in trading today.</p>\n<p>At last check Wednesday, the stock was down 38.30% at $7.39.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2158528016","content_text":"AppHarvest Inc (NASDAQ:APPH) is trading significantly lower Wednesday after the company announced worse-than-expected second-quarter financial results and cut guidance.\nAppHarvest reported a quarterly earnings loss of 32 cents per share, which came in below the estimate for a loss of 19 cents per share. The company reported quarterly revenue of $3.1 million, which came in below the estimate of $5.87 million.\nAppHarvest lowered its full-year 2021 revenue guidance from a range of $20 million to $25 million to a range of $7 million to $9 million.\n“We believe our innovative, sustainable approach, which captures free rainwater and sunlight through large glass roofs in Appalachia and leverages world-class technology at scale while maintaining the highest ESG principles, positions our company to be a global leader in this industry,” said Jonathan Webb, founder and CEO of AppHarvest.\nAppHarvest is an agriculture technology company engaged in developing and operating controlled environment indoor farms.\nPrice Action: AppHarvest is making a new 52-week low in trading today.\nAt last check Wednesday, the stock was down 38.30% at $7.39.","news_type":1},"isVote":1,"tweetType":1,"viewCount":66,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147914760,"gmtCreate":1626327004750,"gmtModify":1633927818757,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/147914760","repostId":"2151548988","repostType":4,"repost":{"id":"2151548988","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626292832,"share":"https://www.laohu8.com/m/news/2151548988?lang=&edition=full","pubTime":"2021-07-15 04:00","market":"us","language":"en","title":"S&P 500 ends higher after Powell lulls market","url":"https://stock-news.laohu8.com/highlight/detail?id=2151548988","media":"Reuters","summary":"Powell says economy 'a ways off' from bond taper.BofA slips as low interest rates hurt lending business.July 14  - The S&P 500 ended with a gain after briefly hitting an intra-day record in a choppy session on Wednesday, as investors balanced worries about inflation with reassuring comments from Fed Chair Jerome Powell.Of the 11 S&P 500 sector indexes, utilities and consumer staples were among the strongest, while energy sank over 3%.U.S. monetary policy will offer \"powerful support\" to the econ","content":"<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)</p>\n<ul>\n <li>Powell says economy 'a ways off' from bond taper.</li>\n <li>BofA slips as low interest rates hurt lending business.</li>\n <li>American Airlines up on positive forecast.</li>\n</ul>\n<p>July 14 (Reuters) - The S&amp;P 500 ended with a gain after briefly hitting an intra-day record in a choppy session on Wednesday, as investors balanced worries about inflation with reassuring comments from Fed Chair Jerome Powell.</p>\n<p>Of the 11 S&amp;P 500 sector indexes, utilities and consumer staples were among the strongest, while energy sank over 3%.</p>\n<p>U.S. monetary policy will offer \"powerful support\" to the economy \"until the recovery is complete,\" Powell told a congressional hearing in remarks that portrayed a recent jump in inflation as temporary and focused on the need for continued job growth.</p>\n<p>Powell's comments followed data this week showing U.S. producer prices increased more than expected in June and U.S. consumer prices rose by the most in 13 years.</p>\n<p>Investors in recent weeks have focused on inflation, with many fearing a possible hawkish shift by the Federal Reserve, as well as a spike in coronavirus infections that could knock U.S. equities off record highs.</p>\n<p>With banks kicking off second-quarter earnings season this week, analysts expect 66% growth in earnings per share for S&amp;P 500 companies, according to IBES estimate data from Refinitiv.</p>\n<p>The S&amp;P 500 is up about 16% so far this year, leading many investors to worry that the stock market rally may run out of steam, and they are looking to earnings to potentially provide more fuel.</p>\n<p>\"Everyone knows earnings are going to be very strong. The question is how the market reacts to those earnings, and what are the outlooks given by management. That is more critical than anything,\" said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.</p>\n<p>Apple Inc hit a record high after Bloomberg reported that the company wants suppliers to increase production of its upcoming iPhone by about 20%.</p>\n<p>Microsoft also hit a record high after saying it will offer its Windows operating system as a cloud-based service, aiming to make it easier to access business apps that need Windows from a broader range of devices.</p>\n<p>Microsoft and Apple supported the S&amp;P 500 more than any other stocks.</p>\n<p>$Bank of America Corp(BAC-N)$ dropped after the lender posted its quarterly results and detailed its sensitivity to low interest rates</p>\n<p>Wells Fargo rose after it swung to a profit in the second quarter, smashing Wall Street expectations. Citigroup</p>\n<p>fell after comfortably beat market estimates for second-quarter profits.</p>\n<p>Those reports followed strong results on Tuesday from JPMorgan Chase &amp; Co and Goldman Sachs Group Inc .</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 0.12% to end at 34,930.34 points, while the S&amp;P 500 gained 0.10% to 4,373.55.</p>\n<p>The Nasdaq Composite dropped 0.26% to 14,639.60.</p>\n<p>American Airlines rallied after it forecast positive cash flow.</p>\n<p>Lululemon Athletica jumped after Goldman Sachs called the yoga pants seller a \"top idea\" as apparel makers benefit from the economic reopening.</p>\n<p>(Reporting by Noel Randewich; Additional reporting by Devik Jain and Shreyashi Sanyal in Bengaluru; Editing by Maju Samuel and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 ends higher after Powell lulls market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 ends higher after Powell lulls market\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-15 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)</p>\n<ul>\n <li>Powell says economy 'a ways off' from bond taper.</li>\n <li>BofA slips as low interest rates hurt lending business.</li>\n <li>American Airlines up on positive forecast.</li>\n</ul>\n<p>July 14 (Reuters) - The S&amp;P 500 ended with a gain after briefly hitting an intra-day record in a choppy session on Wednesday, as investors balanced worries about inflation with reassuring comments from Fed Chair Jerome Powell.</p>\n<p>Of the 11 S&amp;P 500 sector indexes, utilities and consumer staples were among the strongest, while energy sank over 3%.</p>\n<p>U.S. monetary policy will offer \"powerful support\" to the economy \"until the recovery is complete,\" Powell told a congressional hearing in remarks that portrayed a recent jump in inflation as temporary and focused on the need for continued job growth.</p>\n<p>Powell's comments followed data this week showing U.S. producer prices increased more than expected in June and U.S. consumer prices rose by the most in 13 years.</p>\n<p>Investors in recent weeks have focused on inflation, with many fearing a possible hawkish shift by the Federal Reserve, as well as a spike in coronavirus infections that could knock U.S. equities off record highs.</p>\n<p>With banks kicking off second-quarter earnings season this week, analysts expect 66% growth in earnings per share for S&amp;P 500 companies, according to IBES estimate data from Refinitiv.</p>\n<p>The S&amp;P 500 is up about 16% so far this year, leading many investors to worry that the stock market rally may run out of steam, and they are looking to earnings to potentially provide more fuel.</p>\n<p>\"Everyone knows earnings are going to be very strong. The question is how the market reacts to those earnings, and what are the outlooks given by management. That is more critical than anything,\" said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.</p>\n<p>Apple Inc hit a record high after Bloomberg reported that the company wants suppliers to increase production of its upcoming iPhone by about 20%.</p>\n<p>Microsoft also hit a record high after saying it will offer its Windows operating system as a cloud-based service, aiming to make it easier to access business apps that need Windows from a broader range of devices.</p>\n<p>Microsoft and Apple supported the S&amp;P 500 more than any other stocks.</p>\n<p>$Bank of America Corp(BAC-N)$ dropped after the lender posted its quarterly results and detailed its sensitivity to low interest rates</p>\n<p>Wells Fargo rose after it swung to a profit in the second quarter, smashing Wall Street expectations. Citigroup</p>\n<p>fell after comfortably beat market estimates for second-quarter profits.</p>\n<p>Those reports followed strong results on Tuesday from JPMorgan Chase &amp; Co and Goldman Sachs Group Inc .</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 0.12% to end at 34,930.34 points, while the S&amp;P 500 gained 0.10% to 4,373.55.</p>\n<p>The Nasdaq Composite dropped 0.26% to 14,639.60.</p>\n<p>American Airlines rallied after it forecast positive cash flow.</p>\n<p>Lululemon Athletica jumped after Goldman Sachs called the yoga pants seller a \"top idea\" as apparel makers benefit from the economic reopening.</p>\n<p>(Reporting by Noel Randewich; Additional reporting by Devik Jain and Shreyashi Sanyal in Bengaluru; Editing by Maju Samuel and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","OEF":"标普100指数ETF-iShares","SPY":"标普500ETF","IVV":"标普500指数ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","UPRO":"三倍做多标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯","OEX":"标普100","SDS":"两倍做空标普500ETF",".IXIC":"NASDAQ Composite","POWL":"Powell Industries","SSO":"两倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151548988","content_text":"(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)\n\nPowell says economy 'a ways off' from bond taper.\nBofA slips as low interest rates hurt lending business.\nAmerican Airlines up on positive forecast.\n\nJuly 14 (Reuters) - The S&P 500 ended with a gain after briefly hitting an intra-day record in a choppy session on Wednesday, as investors balanced worries about inflation with reassuring comments from Fed Chair Jerome Powell.\nOf the 11 S&P 500 sector indexes, utilities and consumer staples were among the strongest, while energy sank over 3%.\nU.S. monetary policy will offer \"powerful support\" to the economy \"until the recovery is complete,\" Powell told a congressional hearing in remarks that portrayed a recent jump in inflation as temporary and focused on the need for continued job growth.\nPowell's comments followed data this week showing U.S. producer prices increased more than expected in June and U.S. consumer prices rose by the most in 13 years.\nInvestors in recent weeks have focused on inflation, with many fearing a possible hawkish shift by the Federal Reserve, as well as a spike in coronavirus infections that could knock U.S. equities off record highs.\nWith banks kicking off second-quarter earnings season this week, analysts expect 66% growth in earnings per share for S&P 500 companies, according to IBES estimate data from Refinitiv.\nThe S&P 500 is up about 16% so far this year, leading many investors to worry that the stock market rally may run out of steam, and they are looking to earnings to potentially provide more fuel.\n\"Everyone knows earnings are going to be very strong. The question is how the market reacts to those earnings, and what are the outlooks given by management. That is more critical than anything,\" said Tim Ghriskey, chief investment strategist at Inverness Counsel in New York.\nApple Inc hit a record high after Bloomberg reported that the company wants suppliers to increase production of its upcoming iPhone by about 20%.\nMicrosoft also hit a record high after saying it will offer its Windows operating system as a cloud-based service, aiming to make it easier to access business apps that need Windows from a broader range of devices.\nMicrosoft and Apple supported the S&P 500 more than any other stocks.\n$Bank of America Corp(BAC-N)$ dropped after the lender posted its quarterly results and detailed its sensitivity to low interest rates\nWells Fargo rose after it swung to a profit in the second quarter, smashing Wall Street expectations. Citigroup\nfell after comfortably beat market estimates for second-quarter profits.\nThose reports followed strong results on Tuesday from JPMorgan Chase & Co and Goldman Sachs Group Inc .\nUnofficially, the Dow Jones Industrial Average rose 0.12% to end at 34,930.34 points, while the S&P 500 gained 0.10% to 4,373.55.\nThe Nasdaq Composite dropped 0.26% to 14,639.60.\nAmerican Airlines rallied after it forecast positive cash flow.\nLululemon Athletica jumped after Goldman Sachs called the yoga pants seller a \"top idea\" as apparel makers benefit from the economic reopening.\n(Reporting by Noel Randewich; Additional reporting by Devik Jain and Shreyashi Sanyal in Bengaluru; Editing by Maju Samuel and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":135284453,"gmtCreate":1622165412672,"gmtModify":1634183242522,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/135284453","repostId":"1148985369","repostType":4,"isVote":1,"tweetType":1,"viewCount":135,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":608168615,"gmtCreate":1638667512460,"gmtModify":1638667512582,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/608168615","repostId":"1174181873","repostType":4,"repost":{"id":"1174181873","kind":"news","pubTimestamp":1638578178,"share":"https://www.laohu8.com/m/news/1174181873?lang=&edition=full","pubTime":"2021-12-04 08:36","market":"us","language":"en","title":"US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1174181873","media":"renaissancecap...","summary":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billi","content":"<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.</p>\n<p>Buffett-backed&nbsp;<b>Nu Holdings</b>(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.</p>\n<p>Cloud infrastructure platform&nbsp;<b>HashiCorp</b>(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&amp;M spend.</p>\n<p>Cannabis finance REIT&nbsp;<b>Chicago Atlantic Real Estate Finance</b>(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.</p>\n<p>Canadian gold exploration company&nbsp;<b>Austin Gold</b>(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.</p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Digital banking and cloud infrastructure lead a 4 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-04 08:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"REFI":"Chicago Atlantic Real Estate Finance, Inc.","HCP":"HashiCorp, Inc.","NU":"Nu Holdings Ltd."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89235/US-IPO-Week-Ahead-Digital-banking-and-cloud-infrastructure-lead-a-4-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174181873","content_text":"The IPO market is expected to pick up in the week ahead with four IPOs scheduled to raise $3.7 billion.\nBuffett-backed Nu Holdings(NU) plans to raise $2.5 billion at a $41.1 billion market cap. Operating as Nubank, this Brazilian online-only bank was formed in 2013 to launch a no-fees credit card offering with a mobile-first customer experience, but has since expanded to offer various other financial products. Nu has grown rapidly since its inception, with a current base of nearly 50 million customers, though revenue per customer has been falling as its base grows.\nCloud infrastructure platform HashiCorp(HCP) plans to raise $1.1 billion at a $14.0 billion market cap. This VC-backed company provides a suite of solutions that standardize and automate the provisioning, securing, connecting, and running of cloud infrastructure at scale. While it has demonstrated rapid growth and a sticky customer base, HashiCorp is highly unprofitable due to S&M spend.\nCannabis finance REIT Chicago Atlantic Real Estate Finance(REFI) plans to raise $106 million at a $296 million market cap. This newly-formed REIT is focused on originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate properties. Its current portfolio consists of senior loans to state-licensed operators in the cannabis industry.\nCanadian gold exploration company Austin Gold(AUST) plans to raise $15 million at a $64 million market cap. This Canadian gold exploration company currently has interests in four properties located in the state of Nevada, with just one property that it considers material at this time. Austin Gold has not generated any operating revenues to date.","news_type":1},"isVote":1,"tweetType":1,"viewCount":361,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":817611498,"gmtCreate":1630939773214,"gmtModify":1632905035601,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/817611498","repostId":"1158349328","repostType":4,"repost":{"id":"1158349328","kind":"news","pubTimestamp":1630913486,"share":"https://www.laohu8.com/m/news/1158349328?lang=&edition=full","pubTime":"2021-09-06 15:31","market":"us","language":"en","title":"Why 2021 Is the Kind of Year to Banish the September Stock Blues","url":"https://stock-news.laohu8.com/highlight/detail?id=1158349328","media":"Barron's","summary":"Stocks famously perform poorly in September. But that may not necessarily be the case in a year like","content":"<p>Stocks famously perform poorly in September. But that may not necessarily be the case in a year like 2021.</p>\n<p>Since 1928, the average September return for the S&amp;P 500 has been a 0.99% loss. That makes the month far worse than May, which ranks second in investor gloom with an average loss of 0.11%. But there’s a caveat here. History also finds that Septembers that follow strong gains earlier in the year tended to have positive returns. When the S&amp;P 500 rose by more than 13% over the first six months, the median September gain since 1928 rang in at 1.4%, according to Fundstrat.</p>\n<p>Over that 93-year span, the S&amp;P fell in 54% of the Septembers. But when markets rose from January through June, 63% of the Septembers saw positive gains. Through June of this year, the S&amp;P 500 rallied 14%.</p>\n<p><img src=\"https://static.tigerbbs.com/dc9b7962b08fe42d27d182d586cf20e4\" tg-width=\"778\" tg-height=\"440\" referrerpolicy=\"no-referrer\">A similar trend applies to the year. Strategists atWells Fargo recently lifted their target for the S&amp;P 500 to a level that reflects more than 6% upside from current prices. Using data back to 1990, they say that in years in which the S&amp;P sees double-digit percentage gains for the first eight months, it rises another 8% to finish the year.</p>\n<p><img src=\"https://static.tigerbbs.com/23718a745d8c03556be0411afdf1af64\" tg-width=\"792\" tg-height=\"438\" referrerpolicy=\"no-referrer\">The S&amp;P 500 closed on Thursday at 4523, ending August with a year-to-date gain of 20.4%. But be aware of one thing: The ride could be bumpy. The S&amp;P 500 hasn’t had a pullback of more than 5% this year. With risks on the horizon—the Delta variant, inflation, high valuations, even a corporate-tax increase—stocks could easily correct. “Markets are ‘overbought’ and due for a pullback,” writes Fundstrat research head Tom Lee. Perhaps, but don’t be surprised if this market bucks the September blues.</p>\n<p><b>This&nbsp;Week&nbsp;</b></p>\n<p><b>Monday 9/6</b></p>\n<p><b>Stock and fixed-income</b> markets are closed in observance of Labor Day.</p>\n<p><b>Tuesday 9/7</b></p>\n<p>Casey’s General Stores and Coupa Software announce earnings.</p>\n<p><b>Wednesday 9/8</b></p>\n<p>Copart, GameStop,&nbsp;and Lululemon Athletica&nbsp;release quarterly results.</p>\n<p>Analog Devices hosts a conference call to discuss its capital-allocation plans and update its outlook for fiscal 2021. The company recently closed its $21 billion acquisition of Maxim Integrated Products.</p>\n<p>Global Payments, Johnson Controls International,&nbsp;and ResMed&nbsp;hold virtual investor days.</p>\n<p><b>The Bureau of Labor</b>&nbsp;Statistics releases the Job Openings and Labor Turnover Survey. Consensus estimate is for 10 million job openings on the last business day of July. In June, there were 10.1 million openings, the fourth consecutive monthly record.</p>\n<p><b>The Federal Reserve</b> reports consumer credit data for July. Total outstanding consumer debt increased by $37.7 billion to a record $4.32 trillion in June. For the second quarter, consumer credit rose at a seasonally adjusted annual rate of 8.8%, reflecting pent-up demand.</p>\n<p><b>The Federal Reserve</b> releases the beige book for the sixth of eight times this year. The report summarizes current economic conditions among the 12 Federal Reserve districts.</p>\n<p><b>Thursday 9/9</b></p>\n<p>Home Depot&nbsp;hosts a conference call to discuss its ESG strategy, led by Ron Jarvis, the company’s chief sustainability officer.</p>\n<p>Moderna hosts its fifth annual R&amp;D day to discuss vaccines in the company’s pipeline. CEO Stéphane Bancel will be among the presenters.</p>\n<p>Danaher holds an investor and analyst meeting, hosted by its CEO Rainer Blair.</p>\n<p>International Paper,&nbsp;Synchrony Financial,&nbsp;and Willis Towers Watson hold investor days.</p>\n<p><b>The European Central</b>&nbsp;Bank announces its monetary-policy decision. The ECB is expected to keep its key interest rate unchanged at minus 0.5%.</p>\n<p><b>The Department of Labor</b>&nbsp;reports initial jobless claims for the week ending on Sept. 4. In August, claims averaged 355,000 a week, the lowest since the pandemic’s onset. This will also be the last week that the extra $300 from federal enhanced unemployment benefits is available. They are set to expire by Sept. 6.</p>\n<p><b>Friday 9/10</b></p>\n<p><b>The BLS reports</b>the producer price index for August. Economists forecast a 0.6% monthly rise along with a 0.5% increase for the core PPI, which excludes volatile food and energy prices. Both jumped 1% in July.</p>\n<p>Kroger&nbsp;holds a conference calls to discuss earnings.&nbsp;Albemarle and Bio-Techne host their 2021 investor days.</p>","source":"lsy1610680873436","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why 2021 Is the Kind of Year to Banish the September Stock Blues </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy 2021 Is the Kind of Year to Banish the September Stock Blues \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-06 15:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/september-stock-market-outlook-51630703979?mod=markets><strong>Barron's</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stocks famously perform poorly in September. But that may not necessarily be the case in a year like 2021.\nSince 1928, the average September return for the S&P 500 has been a 0.99% loss. That makes ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/september-stock-market-outlook-51630703979?mod=markets\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/september-stock-market-outlook-51630703979?mod=markets","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158349328","content_text":"Stocks famously perform poorly in September. But that may not necessarily be the case in a year like 2021.\nSince 1928, the average September return for the S&P 500 has been a 0.99% loss. That makes the month far worse than May, which ranks second in investor gloom with an average loss of 0.11%. But there’s a caveat here. History also finds that Septembers that follow strong gains earlier in the year tended to have positive returns. When the S&P 500 rose by more than 13% over the first six months, the median September gain since 1928 rang in at 1.4%, according to Fundstrat.\nOver that 93-year span, the S&P fell in 54% of the Septembers. But when markets rose from January through June, 63% of the Septembers saw positive gains. Through June of this year, the S&P 500 rallied 14%.\nA similar trend applies to the year. Strategists atWells Fargo recently lifted their target for the S&P 500 to a level that reflects more than 6% upside from current prices. Using data back to 1990, they say that in years in which the S&P sees double-digit percentage gains for the first eight months, it rises another 8% to finish the year.\nThe S&P 500 closed on Thursday at 4523, ending August with a year-to-date gain of 20.4%. But be aware of one thing: The ride could be bumpy. The S&P 500 hasn’t had a pullback of more than 5% this year. With risks on the horizon—the Delta variant, inflation, high valuations, even a corporate-tax increase—stocks could easily correct. “Markets are ‘overbought’ and due for a pullback,” writes Fundstrat research head Tom Lee. Perhaps, but don’t be surprised if this market bucks the September blues.\nThis Week \nMonday 9/6\nStock and fixed-income markets are closed in observance of Labor Day.\nTuesday 9/7\nCasey’s General Stores and Coupa Software announce earnings.\nWednesday 9/8\nCopart, GameStop, and Lululemon Athletica release quarterly results.\nAnalog Devices hosts a conference call to discuss its capital-allocation plans and update its outlook for fiscal 2021. The company recently closed its $21 billion acquisition of Maxim Integrated Products.\nGlobal Payments, Johnson Controls International, and ResMed hold virtual investor days.\nThe Bureau of Labor Statistics releases the Job Openings and Labor Turnover Survey. Consensus estimate is for 10 million job openings on the last business day of July. In June, there were 10.1 million openings, the fourth consecutive monthly record.\nThe Federal Reserve reports consumer credit data for July. Total outstanding consumer debt increased by $37.7 billion to a record $4.32 trillion in June. For the second quarter, consumer credit rose at a seasonally adjusted annual rate of 8.8%, reflecting pent-up demand.\nThe Federal Reserve releases the beige book for the sixth of eight times this year. The report summarizes current economic conditions among the 12 Federal Reserve districts.\nThursday 9/9\nHome Depot hosts a conference call to discuss its ESG strategy, led by Ron Jarvis, the company’s chief sustainability officer.\nModerna hosts its fifth annual R&D day to discuss vaccines in the company’s pipeline. CEO Stéphane Bancel will be among the presenters.\nDanaher holds an investor and analyst meeting, hosted by its CEO Rainer Blair.\nInternational Paper, Synchrony Financial, and Willis Towers Watson hold investor days.\nThe European Central Bank announces its monetary-policy decision. The ECB is expected to keep its key interest rate unchanged at minus 0.5%.\nThe Department of Labor reports initial jobless claims for the week ending on Sept. 4. In August, claims averaged 355,000 a week, the lowest since the pandemic’s onset. This will also be the last week that the extra $300 from federal enhanced unemployment benefits is available. They are set to expire by Sept. 6.\nFriday 9/10\nThe BLS reportsthe producer price index for August. Economists forecast a 0.6% monthly rise along with a 0.5% increase for the core PPI, which excludes volatile food and energy prices. Both jumped 1% in July.\nKroger holds a conference calls to discuss earnings. Albemarle and Bio-Techne host their 2021 investor days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814339036,"gmtCreate":1630759447125,"gmtModify":1632906013065,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/814339036","repostId":"2164803577","repostType":4,"repost":{"id":"2164803577","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630699233,"share":"https://www.laohu8.com/m/news/2164803577?lang=&edition=full","pubTime":"2021-09-04 04:00","market":"us","language":"en","title":"Tech lifts Nasdaq to record close but Wall Street mixed on jobs report","url":"https://stock-news.laohu8.com/highlight/detail?id=2164803577","media":"Reuters","summary":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slu","content":"<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech lifts Nasdaq to record close but Wall Street mixed on jobs report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech lifts Nasdaq to record close but Wall Street mixed on jobs report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-04 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Dismal August jobs report calms taper fears</li>\n <li>Leisure, retail employment disappoint; cruise liners slump</li>\n <li>Banking stocks slide, shrug off jump in bond yields</li>\n</ul>\n<p>Sept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.</p>\n<p>A majority of the 11 S&amp;P sectors ended lower, with the energy and financial indexes among those finishing in the red.</p>\n<p>Banking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.</p>\n<p>\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.</p>\n<p>\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"</p>\n<p>Among the biggest decliners on the S&amp;P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.</p>\n<p>The S&amp;P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.</p>\n<p>The labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.</p>\n<p>On Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.</p>\n<p>Despite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&amp;P movement in the wake of a wide miss on the payrolls report.</p>\n<p>Unofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&amp;P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite&nbsp;added 32.34 points, or 0.21%, to 15,363.52.</p>\n<p>The Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and <a href=\"https://laohu8.com/S/FB\">Facebook</a>. Tech stocks tend to perform better in a low interest-rate environment.</p>\n<p>Chinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.</p>\n<p>Biotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164803577","content_text":"Dismal August jobs report calms taper fears\nLeisure, retail employment disappoint; cruise liners slump\nBanking stocks slide, shrug off jump in bond yields\n\nSept 3 (Reuters) - The Nasdaq closed Friday at a fresh record but Wall Street's main indexes headed into the Labor Day weekend in mixed fashion, reacting to a disappointing U.S. jobs report which raised fears about the pace of economic recovery but weakened the argument for near-term tapering.\nA majority of the 11 S&P sectors ended lower, with the energy and financial indexes among those finishing in the red.\nBanking stocks, which generally perform better when bond yields are higher, dropped even as the benchmark 10-year Treasury yield jumped following the report.\n\"The number's a big disappointment and it's clear the Delta variant had a negative impact on the labor economy this summer,\" said Michael Arone, chief investment strategist at State Street Global Advisors in Boston.\n\"You can tell because leisure and hospitality didn't add any jobs and retail actually lost jobs. Investors will conclude that perhaps this will put the (Federal Reserve) further on hold in terms of the timing of tapering. Markets may be okay with that.\"\nAmong the biggest decliners on the S&P 500 were cruise ship operators, including Norwegian Cruise Line Holdings , Carnival Corp and Royal Caribbean Cruises , whose businesses are highly susceptible to consumer sentiment around travel and COVID-19.\nThe S&P 500 and the Nasdaq had scaled all-time highs over the past few weeks on support from robust corporate earnings, but investors have remained generally cautious as they watch economic indicators and the jump in U.S. infections to see how that might influence the Fed and its tapering plans.\nThe labor market remains the key touchstone for the Fed, with Chair Jerome Powell hinting last week that reaching full employment was a pre-requisite for the central bank to start paring back its asset purchases.\nOn Friday, the Labor Department's closely watched report showed nonfarm payrolls increased by 235,000 jobs in August, widely missing economists' estimate of 750,000. Payrolls had surged 1.05 million in July.\nDespite a number well outside the consensus estimate, the overall reaction of investors was muted, continuing a trend over the last year of a decoupling of significant S&P movement in the wake of a wide miss on the payrolls report.\nUnofficially, the Dow Jones Industrial Average fell 74.47 points, or 0.21%, to 35,369.35, the S&P 500 lost 1.41 points, or 0.03%, to 4,535.54 and the Nasdaq Composite added 32.34 points, or 0.21%, to 15,363.52.\nThe Nasdaq, registering a fifth daily gain in the last six sessions, was boosted by technology heavyweights, including Apple , Alphabet , and Facebook. Tech stocks tend to perform better in a low interest-rate environment.\nChinese ride-hailing firm Didi Global gained after a media report that the city of Beijing was considering moves that would give state entities control of the company.\nBiotechnology firm Forte Biosciences slumped after its experimental treatment for eczema, a skin disease, failed to meet its main goal.\n(Reporting by Shashank Nayar in Bengaluru and Stephen Culp and David French in New York; Editing by Arun Koyyur and Marguerita Choy)","news_type":1},"isVote":1,"tweetType":1,"viewCount":247,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814397066,"gmtCreate":1630758936755,"gmtModify":1632906014547,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/814397066","repostId":"1194566233","repostType":4,"isVote":1,"tweetType":1,"viewCount":260,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813713552,"gmtCreate":1630246098076,"gmtModify":1704957419749,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/813713552","repostId":"1129129956","repostType":4,"repost":{"id":"1129129956","kind":"news","pubTimestamp":1630201285,"share":"https://www.laohu8.com/m/news/1129129956?lang=&edition=full","pubTime":"2021-08-29 09:41","market":"us","language":"en","title":"This Unloved Tech Stock Could Make You Rich One Day","url":"https://stock-news.laohu8.com/highlight/detail?id=1129129956","media":"Motley Fool","summary":"The iBuying business is a race to grow larger, and Opendoor is winning.The company is growing at a rate that is two years ahead of what management projected just a year earlier.The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.Real estate iBuying company Opendoor Technologieshas been executing at a high level in the three quarters since coming public via a special purpose acquisition company  merger. In a race to disrupt residential ","content":"<p>Key Points</p>\n<ul>\n <li>The iBuying business is a race to grow larger, and Opendoor is winning.</li>\n <li>The company is growing at a rate that is two years ahead of what management projected just a year earlier.</li>\n <li>The market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.</li>\n</ul>\n<p></p>\n<p>Real estate iBuying company&nbsp;<b>Opendoor Technologies</b>(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.</p>\n<p>Despite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.</p>\n<h3>1. Opendoor is winning the iBuying battle</h3>\n<p>The traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.</p>\n<p>Opendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.</p>\n<p>After seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including&nbsp;<b>Zillow Group</b>&nbsp;and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.</p>\n<p>According to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.</p>\n<h3>2. Revenue growth is ahead of schedule</h3>\n<p>When companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.</p>\n<p>Fast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"</p>\n<p>In other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.</p>\n<h3>3. SPACs are out of favor with the market... opportunity?</h3>\n<p>Investors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.</p>\n<p>Investors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.</p>\n<p>But if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.</p>\n<p>Competitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.</p>\n<h3>Here's the bottom line</h3>\n<p>Real estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"<b>Amazon</b>\" of home buying, but what seems certain is that the company is&nbsp;poised to be a big player&nbsp;in real estate's future if it keeps performing like this.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This Unloved Tech Stock Could Make You Rich One Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis Unloved Tech Stock Could Make You Rich One Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-29 09:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OPEN":"Opendoor Technologies Inc"},"source_url":"https://www.fool.com/investing/2021/08/28/this-unloved-tech-stock-may-make-you-rich-one-day/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129129956","content_text":"Key Points\n\nThe iBuying business is a race to grow larger, and Opendoor is winning.\nThe company is growing at a rate that is two years ahead of what management projected just a year earlier.\nThe market is bearish on virtually all SPACs, making Opendoor a bargain that could eventually bring huge returns.\n\n\nReal estate iBuying company Opendoor Technologies(NASDAQ:OPEN)has been executing at a high level in the three quarters since coming public via a special purpose acquisition company (SPAC) merger. In a race to disrupt residential real estate, one of the largest markets in the world, Opendoor's long-term potential could bring big returns for patient investors.\nDespite the upside, the market hasn't yet appreciated Opendoor's accomplishments; the stock is down more than 50% from its highs. There are three important clues that Opendoor could be a compelling investment idea for bold investors.\n1. Opendoor is winning the iBuying battle\nThe traditional home-buying process in the United States is slow and handled by multiple parties, including agents, lawyers, inspectors, and bankers. This creates a lot of back and forth paperwork and drags the process out to more than 30 days, on average.\nOpendoor pioneered the concept of \"iBuying,\" where the buying and selling of a house are digitized, and a company like Opendoor works directly with sellers to provide them with a cash offer and a digital closing process. The company then resells the house on the market. The iBuying process cuts out agents and some of the fees associated with traditional closings, such as agent commissions. Opendoor then resells the house on the market and charges a service fee of up to 5% on the transaction.\nAfter seeing Opendoor steadily grow with its iBuying concept, competitors have also begun to offer iBuying services, including Zillow Group and Offerpad. Because of how capital intensive the business is (a lot of money is needed to buy and sell thousands of houses) and how price competitive the housing market is, these companies are racing to get as big as possible. As the companies buy and sell more homes, they have the ability to become more profitable by leveraging outsourced contractors to save money, and its pricing algorithm improves as it sees more transactions.\nAccording to iBuyerStats, a website dedicated to tracking the competitors found in iBuying, Opendoor has consistently had the most housing inventory available for sale. It currently has roughly 3,300 houses for sale, 53% more than Zillow and more than four times as many as Offerpad.\n2. Revenue growth is ahead of schedule\nWhen companies go public viaSPACmerger, they lay out a public presentation of their business, often including long-term growth projections. Opendoor laid out its pre-merger investor presentation about a year ago, in September 2020.\nFast forward to the company's recent 2021 Q2 earnings call. CEO and founder Eric Wu said on the earnings call, \"... based on our current progress, our second half revenue run rate is on track to exceed our 2023 target, a full two years ahead of plan.\"\nIn other words, if Opendoor were to operate for 12 months at the level the business currently is, it would surpass the $9.8 billion in revenue it projected for 2023. This is an underlooked point because if Opendoor is already two years ahead of its original growth curve, where will it be by 2023? Sure, a dip in the housing market or other events could disrupt the company's speed of growth, but Opendoor is showing the world that the business is operating at a high level.\n3. SPACs are out of favor with the market... opportunity?\nInvestors have overlooked this strong performance, focusing instead on the fact that Opendoor joined the public market via SPAC merger. It has hardly mattered what operating results or earnings have looked like for former SPACs; the stock market has been selling off virtually all SPAC-based stocks for several months now.\nInvestors have been spooked by a handful of \"bad apple\" companies turning up fraudulent, and other companies have wildly missed on the projections they made before going public. These instances have burned those involved, and investors have taken a much more cautious attitude toward SPACs as a whole.\nBut if companies like Opendoor keep blowing away estimates, the market is likely to come around eventually. When it does, the stock price could move aggressively. If we take Eric Wu's comments about revenue and assume that Opendoor does sales of $10 billion in 2022 (in other words, Opendoor stops growing and maintains its current pace over the following year), the stock currently trades at aprice-to-sales(P/S) ratio of just 1.0. That's a bargain-bin valuation.\nCompetitor Zillow Group trades at a P/S ratio of more than 3, reflecting Opendoor's discount as a former SPAC.\nHere's the bottom line\nReal estate is a huge market, and it's a complicated industry because of the clash between traditional agents and the \"new kids\" on the block trying to bring technology into homebuying. It's too early to say that Opendoor will become the \"Amazon\" of home buying, but what seems certain is that the company is poised to be a big player in real estate's future if it keeps performing like this.","news_type":1},"isVote":1,"tweetType":1,"viewCount":101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892010131,"gmtCreate":1628610178323,"gmtModify":1633745730422,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/892010131","repostId":"2158254477","repostType":4,"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891905781,"gmtCreate":1628313399743,"gmtModify":1633751713728,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/891905781","repostId":"1119792130","repostType":4,"isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899171749,"gmtCreate":1628171509381,"gmtModify":1633752962623,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/899171749","repostId":"1121539393","repostType":4,"repost":{"id":"1121539393","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628171164,"share":"https://www.laohu8.com/m/news/1121539393?lang=&edition=full","pubTime":"2021-08-05 21:46","market":"us","language":"en","title":"Lemonade drops over 12% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1121539393","media":"Tiger Newspress","summary":"(Aug 5)  Lemonade, Inc. stock drops over 12% after online insurers sales decline, losses widen.","content":"<p>(Aug 5)&nbsp; <a href=\"https://laohu8.com/S/LMND\">Lemonade, Inc.</a> stock drops over 12% after online insurers sales decline, losses widen.</p>\n<p><img src=\"https://static.tigerbbs.com/6825a39000754135d042cb3962be5c5b\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lemonade drops over 12% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLemonade drops over 12% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-05 21:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Aug 5)&nbsp; <a href=\"https://laohu8.com/S/LMND\">Lemonade, Inc.</a> stock drops over 12% after online insurers sales decline, losses widen.</p>\n<p><img src=\"https://static.tigerbbs.com/6825a39000754135d042cb3962be5c5b\" tg-width=\"1129\" tg-height=\"653\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LMND":"Lemonade, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121539393","content_text":"(Aug 5)  Lemonade, Inc. stock drops over 12% after online insurers sales decline, losses widen.","news_type":1},"isVote":1,"tweetType":1,"viewCount":19,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":178304892,"gmtCreate":1626786983716,"gmtModify":1633771064345,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/178304892","repostId":"1110710903","repostType":4,"repost":{"id":"1110710903","kind":"news","pubTimestamp":1626785016,"share":"https://www.laohu8.com/m/news/1110710903?lang=&edition=full","pubTime":"2021-07-20 20:43","market":"us","language":"en","title":"Panic!? Taco Bell And Starbucks Warn About Shortages","url":"https://stock-news.laohu8.com/highlight/detail?id=1110710903","media":"zerohedge","summary":"Supply chain problems continue to plague the restaurant industry, leading big chains Taco Bell and S","content":"<p>Supply chain problems continue to plague the restaurant industry, leading big chains Taco Bell and Starbucks to warn consumers on Monday that some items may not be available.</p>\n<p>Starbucks told customers on its app that \"due to supply shortages, some items are temporarily unavailable.\"</p>\n<p>That echoed warnings that have persisted at the chain's locations for months. Consumers have complained on social media channels about periodic shortages of items such as green tea.</p>\n<p>At Taco Bell, customers are complaining about a lack of hot sauce. The Mexican fast-food chain's website warns customers that not all items are available at the moment.</p>\n<p><i>\"Sorry if we can't feed your current crave. Due to national ingredient shortages and delivery delays, we may be out of some items,\" an orange banner with bold lettering read on the top of Taco Bell's website.</i></p>\n<p>The company, owned by Louisville, Ky.-based Yum Brands, blamed transportation problems for the shortages.</p>\n<p><i>\"Due to national transportation delays happening throughout most of the industry, we may be temporarily out of some items,\" the company said in a statement. \"Apologies for the inconvenience and we hope to feed fans' current Taco Bell cravings again soon.\"</i></p>\n<p>Restaurants have faced shortages of everything from sauces to pickles to chicken wings in recent months due to a host of issues—including weather problems in Texas and intense demand from consumers coupled with supply limitations.</p>\n<p>But transportation issues have made matters worse. An economywide lack of drivers has made it difficult for companies to deliver goods to their destination.</p>\n<p>Rick Cardenas, president of Olive Garden owner Darden Restaurants, told investors last month that any supply chain issues his company has is over warehousing and transportation problems and not an actual shortage of supplies.</p>\n<p>\"The few spot outages we have are due to warehouse staffing and driver shortages, not product availability,\" Cardenas said, according to a transcript on the financial services site Sentieo.</p>\n<p>* * *</p>\n<p>... and, of course, those who frequent Taco Bell have been all over social media voicing their outrage at how they can't purchase their favorite menu items.</p>\n<p><i>\"Taco Bell employee told me there was a 'national shortage of everything right now,' and I have decided to get my economic news exclusively from drive-thru employees from now on,\" tweeted one patron.</i></p>\n<p><img src=\"https://static.tigerbbs.com/3d5288c106b50a6df5e725de95f2b1ba\" tg-width=\"512\" tg-height=\"261\" referrerpolicy=\"no-referrer\"></p>\n<p>\"Taco Bell has a 'district-wide shortage of hot sauce...times are tough,\" tweeted a customer.</p>\n<p><img src=\"https://static.tigerbbs.com/31d15a425952a4dc5d4ba4f9f225b264\" tg-width=\"510\" tg-height=\"552\" referrerpolicy=\"no-referrer\">Another said:</p>\n<p><img src=\"https://static.tigerbbs.com/41b414c409453a63139c257be29d67e2\" tg-width=\"510\" tg-height=\"259\" referrerpolicy=\"no-referrer\">\"Due to national ingredient shortages and delivery delays, we may be out of some food and beverage items,\" a sign at a Taco Bell drive-thru read.</p>\n<p>Also, a \"shredded cheese shortage\"?</p>\n<p><img src=\"https://static.tigerbbs.com/ff103a977f542c8e06783d7295da19c0\" tg-width=\"517\" tg-height=\"489\" width=\"100%\" height=\"auto\"></p>\n<p>Others say they're \"about to freak out.\"</p>\n<p><img src=\"https://static.tigerbbs.com/0426e68487cbb23f4f395a9464feefda\" tg-width=\"514\" tg-height=\"847\" width=\"100%\" height=\"auto\"></p>\n<p>Rough times in America when consumers are used to the instant gratification of obtaining almost any item or service at their fingertips. Shortages are pushing some to the edge of insanity over petty things, like fast-food tacos.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Panic!? Taco Bell And Starbucks Warn About Shortages</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPanic!? Taco Bell And Starbucks Warn About Shortages\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-20 20:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.zerohedge.com/markets/taco-bell-and-starbucks-warn-about-shortages><strong>zerohedge</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Supply chain problems continue to plague the restaurant industry, leading big chains Taco Bell and Starbucks to warn consumers on Monday that some items may not be available.\nStarbucks told customers ...</p>\n\n<a href=\"https://www.zerohedge.com/markets/taco-bell-and-starbucks-warn-about-shortages\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SBUX":"星巴克"},"source_url":"https://www.zerohedge.com/markets/taco-bell-and-starbucks-warn-about-shortages","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110710903","content_text":"Supply chain problems continue to plague the restaurant industry, leading big chains Taco Bell and Starbucks to warn consumers on Monday that some items may not be available.\nStarbucks told customers on its app that \"due to supply shortages, some items are temporarily unavailable.\"\nThat echoed warnings that have persisted at the chain's locations for months. Consumers have complained on social media channels about periodic shortages of items such as green tea.\nAt Taco Bell, customers are complaining about a lack of hot sauce. The Mexican fast-food chain's website warns customers that not all items are available at the moment.\n\"Sorry if we can't feed your current crave. Due to national ingredient shortages and delivery delays, we may be out of some items,\" an orange banner with bold lettering read on the top of Taco Bell's website.\nThe company, owned by Louisville, Ky.-based Yum Brands, blamed transportation problems for the shortages.\n\"Due to national transportation delays happening throughout most of the industry, we may be temporarily out of some items,\" the company said in a statement. \"Apologies for the inconvenience and we hope to feed fans' current Taco Bell cravings again soon.\"\nRestaurants have faced shortages of everything from sauces to pickles to chicken wings in recent months due to a host of issues—including weather problems in Texas and intense demand from consumers coupled with supply limitations.\nBut transportation issues have made matters worse. An economywide lack of drivers has made it difficult for companies to deliver goods to their destination.\nRick Cardenas, president of Olive Garden owner Darden Restaurants, told investors last month that any supply chain issues his company has is over warehousing and transportation problems and not an actual shortage of supplies.\n\"The few spot outages we have are due to warehouse staffing and driver shortages, not product availability,\" Cardenas said, according to a transcript on the financial services site Sentieo.\n* * *\n... and, of course, those who frequent Taco Bell have been all over social media voicing their outrage at how they can't purchase their favorite menu items.\n\"Taco Bell employee told me there was a 'national shortage of everything right now,' and I have decided to get my economic news exclusively from drive-thru employees from now on,\" tweeted one patron.\n\n\"Taco Bell has a 'district-wide shortage of hot sauce...times are tough,\" tweeted a customer.\nAnother said:\n\"Due to national ingredient shortages and delivery delays, we may be out of some food and beverage items,\" a sign at a Taco Bell drive-thru read.\nAlso, a \"shredded cheese shortage\"?\n\nOthers say they're \"about to freak out.\"\n\nRough times in America when consumers are used to the instant gratification of obtaining almost any item or service at their fingertips. Shortages are pushing some to the edge of insanity over petty things, like fast-food tacos.","news_type":1},"isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":152392627,"gmtCreate":1625269039669,"gmtModify":1633942004749,"author":{"id":"3582969710070724","authorId":"3582969710070724","name":"OO_898","avatar":"https://static.tigerbbs.com/9fb3c360d5d7711641a868a144192fc7","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582969710070724","authorIdStr":"3582969710070724"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/152392627","repostId":"1165340887","repostType":4,"isVote":1,"tweetType":1,"viewCount":194,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}